Only this pageAll pages
Powered by GitBook
1 of 31

URSA Initiative in Rhode Island

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

10x Genomics Dataset Repository

Overview

10x Genomics maintains a repository of publicly available datasets generated through three main platforms: Chromium, Visium, and Xenium. The repository includes Chromium single-cell molecular profiles, Visium spatial transcriptomics (ST) data, and Xenium single-cell spatial gene expression measurements. Datasets span a wide range of tissue types, species, and disease states, with each platform offering multiple dataset formats and analysis outputs depending on the assay chosen. As an example, the Human Glioblastoma: Whole Transcriptome Analysis dataset is a Visium dataset containing ST data on fresh frozen human glioblastoma multiforme tissue, and will be referenced throughout this overview to illustrate typical dataset structure and content.

Methodology and Generation

Datasets in the 10x repository are generated using standardized wet-lab and computational protocols specific to each platform. For Visium datasets, tissue is typically obtained from a specialized tissue bank (e.g., BioIVT Asterand, the source for the glioblastoma dataset), encased in a supportive medium, rapidly frozen, and sliced into 10 µm-thick layers. A slice of tissue is placed onto a Visium Gene Expression slide, which is embedded with thousands of microscopic capture spots acting as biological barcodes. The tissue is fixed (typically with methanol), stained with Hematoxylin and Eosin (H&E), and imaged using a microscope such as the Nikon Eclipse Ti2-E. To capture genetic data, a sequencing instrument such as the Illumina NovaSeq 6000 is used to read the RNA in the tissue and build a genomic library accordingly. The resulting data are run through the software Space Ranger to match the genetic code back to the tissue image. In the glioblastoma dataset specifically, this process yielded 3,468 distinct spots occupied by tissue on the slide, with a median of 4,326 genes and 11,596 unique molecular identifier (UMI) counts detected per spot. Figures like these vary by dataset, tissue type, and sequencing depth.

Access and Analysis

To access a dataset, create a free account through 10x Genomics. Navigate to the Datasets page and use the sidebar to filter by platform, software, species, sample/tissue type, and more. Choose a dataset and look at the "Dataset overview" tab for metadata such as the source, preparation, imaging, sequencing, and key metrics. Look at the "Output and supplemental files" tab for the files to download. For most ST analyses, a minimum of four files are needed: the gene expression matrix, available in either HDF5 (.h5) or Matrix Market (.mtx.gz) format, with .h5 preferred because it is a single file and typically smaller; the spatial coordinates, which map each spot to its location on the slide, available in .csv format; the histology image, required for overlaying expression onto the tissue, available in .png format; and the scale factors, required for aligning spot coordinates with the image, available in .json format. As an example, in the glioblastoma dataset, the display text for the .h5 file is "Feature / barcode matrix HDF5 (filtered)," which downloads a file named "filtered_feature_bc_matrix.h5." For the other three files, the display text "Spatial imaging data" downloads a folder named "spatial" that contains "tissue_positions_list.csv," "tissue_hires_image.png," and "scalefactors_json.json."

In terms of analysis, the software toolkit Seurat is designed to help beginners analyze ST data. Seurat contains user-friendly workflows that streamline complex computational steps to visualize where specific genes are active and identify distinct cell types. Other built-in functions of Seurat include clustering, quality control, and data normalization. While Seurat provides a focused framework for ST analysis, there is also a rapidly expanding ecosystem of ST software. To help navigate these options, Gillespie et al. conducted a meta-review synthesizing benchmarking studies across tissue architecture identification, spatially variable gene detection, cell-cell communication analysis, and deconvolution.This paper can be referenced to help with software selection for ST analysis.

In 10x Genomics gene expression matrices, genes are typically identified using HUGO Gene Nomenclature Committee (HGNC) gene symbols, which are unique abbreviations assigned to each human gene. For example, in the glioblastoma .h5 file, the first three genes are MIR1302-2HG, FAM138A, and OR4F5.

Variable / Component
R Class / Data Type
Description
Example / Range
Variable / Component
R Class / Data Type
Description
Example / Range

  1. Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, Srivastava A, Molla G, Madad S, Fernandez-Granda C, Satija R. Nat Biotechnol. 2024 Feb;42(2):293-304.

  2. Gillespie J, Pietrzak M, Song MA, Chung D. Cells. 2025 Jul 10;14(14):1060.

  • Jaume G, Doucet P, Song AH, Lu MY, Almagro-Pérez C, Wagner SJ, Vaidya AJ, Chen RJ, Williamson DF, Kim A, Mahmood F. Adv Neural Inf Process Syst. 2024 Dec 10;37:53798-833.

  • Zhang L, Sagan A, Qin B, Wang H, Kim E, Hu B, Osmanbeyoglu HU. Nucleic Acids Res. 2026 Jan 5;54(1):gkaf1473.

  • Visium-Generated Spatial Transcriptomics Dataset

Row Names (barcodes)

character

unique 16-base pair spatial barcode to identify the physical Visium spot

AAACAGTGTTCCTGGG-1

x

Matrix Object

dgCMatrix

compressed sparse matrix structure that contains all counts

36,601 genes x 3,468 spots

Row Names (features)

Standardized Healthcare Vocabularies

Data Dictionary

Spatial Coordinates

Gene Expression Matrix

References

Resources

Articles

Links

[1]
[2]
Dictionary learning for integrative, multimodal and scalable single-cell analysis.
A Meta-Review of Spatial Transcriptomics Analysis Software.
HEST-1k: A Dataset for Spatial Transcriptomics and Histology Image Analysis.
STAN, a computational framework for inferring spatially informed transcription factor activity.
Human Glioblastoma: Whole Transcriptome Analysis
Analysis, visualization, and integration of spatial datasets with Seurat
Spatial Transcriptomic Data Analysis: A Beginner’s Guide

numeric

horizontal coordinate on the 2D plane of the image

2361 to 10354 pixels

y

numeric

vertical coordinate on the 2D plane of the image

1442 to 10673 pixels

cell

character

duplicate of spatial barcodes maintained by Seurat

AAACAGTGTTCCTGGG-1

character

biological features in HGNC Gene Symbols

OR4F5

Column Names (cells/spots)

character

unique 16-base pair spatial barcode to identify the physical Visium spot

AAACCGTTCGTCCAGG-1

Matrix Values

numeric

raw UMI transcript counts per gene, per spot

0 to 1,118 UMIs

HGNC Gene Search Tool

Datasets

Table of Contents

10x Genomics maintains a repository of publicly available datasets generated through three main platforms: Chromium, Visium, and Xenium. The repository includes Chromium single-cell molecular profiles, Visium spatial transcriptomics (ST) data, and Xenium single-cell spatial gene expression measurements.

The All of Us dataset is a large, longitudinal U.S. health research resource that integrates clinical, behavioral, genomic, and wearable-device data from a diverse participant population.

The Behavioral Risk Factor Surveillance System (BRFSS) was established in 1984 by the U.S. Centers for Disease Control and Prevention (CDC) to collect prevalence data regarding risk behaviors and preventive health practices among adult residents across all 50 states, the District of Columbia, and participating U.S. territories.

The cBioPortal for Cancer Genomics is an open-access, open-source platform for the interactive exploration of multidimensional cancer genomics datasets with an emphasis on multimodal cancer visualization.

The DailyMed Full SPL Dataset refers to the downloadable full release of all drug labels in the United States.

The Healthcare Cost and Utilization Project (HCUP) is a family of databases, software tools, and related products developed through a Federal-State-Industry partnership and sponsored by the Agency for Healthcare Research and Quality (AHRQ).

The Medical Information Mart for Intensive Care (MIMIC) is a publicly available repository of deidentified electronic health record (EHR) data from patients admitted to the Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts.

The National Plan and Provider Enumeration System (NPPES) is the national registry, operated by the Centers for Medicare & Medicaid Services (CMS), that assigns and maintains the National Provider Identifier (NPI) — the standard unique identifier for health care providers in the United States.

The Pediatric Psychiatry Emergency Services (PediPES) dataset consists of electronic health record (EHR) data for patients younger than 18 years old evaluated in the emergency department at Hasbro Children's Emergency Department in Providence, Rhode Island for psychiatric concerns.

The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population.

SyntheticMass is a Synthea-generated data set that contains realistic but fictional residents of the state of Massachusetts.

The SyntheticRI 2026 datasets consist of patient-centric synthetic health records representing the population of Rhode Island.

The Youth Risk Behavior Surveillance System (YRBSS) was established in 1990 by the U.S. Centers for Disease Control and Prevention (CDC) to monitor priority health risk behaviors and experiences that contribute to death, disability, and social problems among youth and young adults in the United States.

Computing Environments

Stronghold

A core component of the URSA Initiative is Brown's Stronghold. Stronghold is a secure computing and storage environment that enables Brown researchers and associates to analyze sensitive data while complying with regulatory or contractual requirements.

Stronghold is maintained by the Brown University's Center for Computation and Visualization (CCV) in the Office of Information Technology (OIT). To learn more about Stronghold, you may refer to CCV's Stronghold Documentation.

URSA Stronghold

URSA Stronghold is one of the research "tenants" within Stronghold. It is collaboratively managed by CCV, the Brown Center for Biomedical Informatics (BCBI), and the Biomedical Informatics, Bioinformatics, and Cyberinfrastructure Enhancement (BIBCE) Core of Advance RI-CTR. URSA Stronghold offers both Linux and Windows computing platforms; database management systems such as Microsoft SQL, PostgreSQL, and MySQL; and, a broad range of data analysis tools including Julia, Python, R, SAS, and Stata.

Researchers may work within the URSA tenant or request their own dedicated Stronghold tenant. Refer to Brown CCV's documentation for more information about available features and how to request a Stronghold tenant.

Oscar

Oscar (Ocean State Center for Advanced Resources) is Brown University's high performance computing cluster. Oscar is maintained and supported by Brown's Center for Computation and Visualization ().

Brown’s are used to determine data access and storage options. Stronghold is the institutionally-designated environment for Risk Level 3, identified datasets that include protected health information () or personally identifiable information (PII). With approval from the data provider, researchers may leverage Brown's high-performance computing environment or other Brown-managed computers for the storage and analysis of (Brown Risk Level 2) datasets. In addition, Brown’s can be used for storage of de-identified data and other research files. Data analysis is initiated "locally" on a researcher's computer while the data remain secure.

MIMIC-IV

National Plan and Provider Enumeration System (NPPES)

Pediatric Psychiatry Emergency Services (PediPES) at Hasbro Children’s

Surveillance, Epidemiology, and End Results (SEER)

SyntheticMass

SyntheticRI 2026: Synthetic Healthcare Records for Rhode Island

Youth Risk Behavior Surveillance System (YRBSS)

10x Genomics Data Repository
All of Us
Behavioral Risk Factor Surveillance System (BRFSS)
cBioPortal for Cancer Genomics
DailyMed SPL Dataset
Healthcare Cost and Utilization Project (HCUP)

Data Storage at Brown

Resources

Links

CCV
Data Risk Classifications
PHI
Oscar
File Service for Researchers
Brown OIT Data Risk Classifications
Brown CCV Computing
Stronghold Documentation
Oscar Documentation

SyntheticMass

Overview

SyntheticMass is a Synthea-generated data set that contains realistic but fictional residents of the state of Massachusetts. The synthetic population aims to statistically mirror the state population in terms of demographics, disease burden, vaccinations, medical visits, and social determinants. [1] Refer to the SyntheticMass website for more information.

There are several data sets available on the SyntheticMass downloads page.

  • Complete SytheticMass data sets: "SyntheticMass Data Version 2 (24 May, 2017)". This ZIP file is quite large (21GB), so make sure you move the file to a location with enough storage before attempting to unzip.

  • Sample data sets (<100MB) containing 100 or 1,000 patient records

  • Specialized data sets that have been generated using Synthea by other study teams. These include COVID-19 data sets, a Childhood Obesity data set and more.

The following versions are available for each data set.

  • CSV ( describing all CSV tables)

  • C-CDA (xml files)

  • FHIR (json files)

  1. MITRE Corporation. (n.d.). . Retrieved May 1, 2024.

  • Walonoski J, Klaus S, Granger E, Hall D, Gregorowicz A, Neyarapally G, Watson A, Eastman J. . Intell Based Med. 2020 Nov;1:100007. doi: 10.1016/j.ibmed.2020.100007. Epub 2020 Oct 2. PMID: 33043312; PMCID: PMC7531559.

  • Walonoski J, Kramer M, Nichols J, Quina A, Moesel C, Hall D, Duffett C, Dube K, Gallagher T, McLachlan S. . J Am Med Inform Assoc. 2018 Mar 1;25(3):230-238. doi: 10.1093/jamia/ocx079. Erratum in: J Am Med Inform Assoc. 2018 Jul 1;25(7):921. PMID: 29025144; PMCID: PMC7651916.

References

Resources

Articles

Links

data dictionary
About Synthea
Synthea™ Novel coronavirus (COVID-19) model and synthetic data set
Synthea: An approach, method, and software mechanism for generating synthetic patients and the synthetic electronic health care record
SyntheticMass Website

Dataset Demographics

NPPES follows a fixed schema, so the full file supports aggregate statistics across the entire registry — summarized below for the most recent monthly release.

Source: npidata_pfile (full file, 2005-05-23 to 2026-04-12). Total records: 9,494,438.

1. Entity Type

Entity Type
Records

1 — Individual

7,236,712

2 — Organization

Status
Records
Sex
Records
Year
New NPIs
State
Providers
Taxonomy Code
Classification (NUCC)
Providers

1,917,366

(blank — deactivated)

340,360

Active

9,154,078

Deactivated

340,360

F — Female

4,952,833

M — Male

2,246,911

X — Undisclosed

35,500

2005

242,759

2006

1,190,765

2007

793,497

CA

1,145,592

NY

645,005

FL

634,992

106S00000X

Behavior Technician

546,913

1041C0700X

Social Worker, Clinical

2. Record Status

3. Sex

4. Enumerations per Year

5. Top 25 States (Practice Location)

Top 25 Primary Taxonomies

U — Undisclosed

1,467

(blank)

1

2008

334,749

2009

242,550

2010

258,206

2011

275,627

2012

286,574

2013

269,626

2014

286,575

2015

297,458

2016

318,321

2017

329,997

2018

391,037

2019

399,994

2020

427,550

2021

463,987

2022

468,470

2023

509,992

2024

548,097

2025

631,472

2026 (partial)

186,775

TX

588,935

OH

395,358

MI

344,935

(blank — deactivated)

340,362

PA

327,945

IL

310,948

NC

267,983

MA

253,121

WA

237,740

NJ

228,549

GA

224,337

MD

207,620

VA

195,085

CO

191,225

AZ

171,484

MN

163,228

TN

156,146

IN

150,919

OR

146,773

MO

145,086

WI

139,254

LA

123,091

341,516

(none — deactivated)

No primary taxonomy on record

340,360

101YM0800X

Counselor, Mental Health

316,829

183500000X

Pharmacist

293,460

225100000X

Physical Therapist

290,096

390200000X

Student in an Organized Health Care Education/Training Program

277,093

363LF0000X

Nurse Practitioner, Family

241,779

235Z00000X

Speech-Language Pathologist

208,312

207Q00000X

Family Medicine (Physician)

206,434

207R00000X

Internal Medicine (Physician)

189,130

1223G0001X

Dentist, General Practice

177,871

363A00000X

Physician Assistant

161,694

171M00000X

Case Manager/Care Coordinator

160,060

101YP2500X

Counselor, Professional

156,214

111N00000X

Chiropractor

152,146

163W00000X

Registered Nurse

143,191

225X00000X

Occupational Therapist

139,532

104100000X

Social Worker

136,288

122300000X

Dentist

122,501

103K00000X

Behavior Analyst

121,669

101Y00000X

Counselor

110,647

106H00000X

Marriage & Family Therapist

107,989

363L00000X

Nurse Practitioner

100,171

101YA0400X

Counselor, Addiction (Substance Use Disorder)

98,615

National Plan and Provider Enumeration System (NPPES)

Overview

The National Plan and Provider Enumeration System (NPPES) is the national registry, operated by the Centers for Medicare & Medicaid Services (CMS), that assigns and maintains the National Provider Identifier (NPI) — the standard unique identifier for health care providers in the United States. Established under the Administrative Simplification provisions of HIPAA, NPPES enumerates both individual clinicians and provider organizations, each of which receives a single, permanent 10-digit NPI used to identify them in administrative and financial transactions such as claims, eligibility checks, and remittances. [1,5] The system holds millions of active and deactivated records and functions as core infrastructure for the U.S. health care system, where the NPI serves as a common key for linking providers across enrollment, claims, and quality datasets.

Methodology and Generation

The data are generated primarily through self-reported provider enumeration. A provider becomes part of NPPES by applying for an NPI and submitting the information that forms the core of its record. [2]

Upon a successful application, NPPES generates and assigns a single 10-position, intelligence-free NPI. The identifier is assigned once, is permanent, and is not affected by later changes to name, address, or other fields; nor is it reused or reassigned to a different provider.5 Because the record is built from provider-supplied information, the database depends on providers to maintain their own data and to submit updates when their circumstances change. To keep provider enrollment and enumeration information aligned, NPPES is integrated with CMS's Provider Enrollment, Chain, and Ownership System (PECOS) through an API. Updates made in PECOS can automatically populate the corresponding NPPES record, helping ensure provider information remains accurate and consistent across both systems.

Records can be deactivated as well as created. NPPES carries a deactivation reason code for each deactivated record — death, disbandment, fraud, or other — together with a deactivation date, and these records are retained (and, since 2018, included in the full monthly file rather than dropped). A deactivated NPI is never reissued to another provider and may be reactivated if the original provider returns to practice. CMS does not independently verify most of the self-reported content of a record, which is the methodological reason the data are comprehensive in coverage but variable in currency and accuracy. The publicly available dataset is the FOIA-disclosable subset of these records, extracted and released on the cycles described in Data Access and Dissemination.

CMS releases only the subset of each NPPES record that is disclosable under the Freedom of Information Act; identifying elements such as Social Security Number, ITIN, and date of birth are withheld. Public dissemination of this FOIA-disclosable data began in September 2007 and is offered through three channels:

  1. NPI Registry — a free, real-time web lookup for individual provider records, suited to verifying or retrieving a single NPI.

  2. NPI Registry API — a public programming interface (npiregistry.cms.hhs.gov) that returns individual records as JSON in response to per-record queries. It is built for record-level lookups and does not provide bulk export.

  3. Downloadable files — the route for working with the dataset in bulk. CMS publishes a full replacement monthly NPI file, weekly incremental files (covering NPIs newly assigned, updated, or deactivated during that week), and a monthly deactivation file in Excel format for users who need only deactivated NPIs and their deactivation dates.

The downloadable package is a single ZIP containing a Read Me, the Code Values reference, a Header (file-layout) document, and the FOIA-disclosable data file itself — a comma-separated file carrying both the header row and the data. Since June 18, 2018, the package has also bundled three reference files that externalize repeating attributes so the main file stays manageable: an Other Name reference file (additional names for Type 2 organizations), a Practice Location reference file (non-primary practice locations for Types 1 and 2), and an Endpoint reference file (health information exchange endpoints for Types 1 and 2). Each links back to the core record by NPI.

The weekly file is supplemental and must be used alongside the most recent monthly full-replacement file, which should be re-downloaded each month to stay current. CMS does not retain historical copies of the downloadable file — each release reflects the present state of NPPES — and the full data file contains several million records (individual and organizational, active and deactivated), making it too large to open directly in standard spreadsheet software.

  1. Centers for Medicare & Medicaid Services (US). [Internet]. Baltimore (MD): CMS; 2006 Mar [cited 2026 Jun 12].

  2. Centers for Medicare & Medicaid Services (US). [Internet]. Baltimore (MD): CMS; [cited 2026 Jun 12].

  3. Centers for Medicare & Medicaid Services (US). [Internet]. Baltimore (MD): CMS; [cited 2026 Jun 12].

  • Bindman AB. Medicare Medicaid Res Rev. 2013;3(3):mmrr.003.03.b03. Published 2013 Jul 30. doi:10.5600/mmrr.003.03.b03. PMID: 24753977; PMCID: PMC3983736.

Centers for Medicare & Medicaid Services (US). [Internet]. Baltimore (MD): CMS; 2011 Jul [cited 2026 Jun 12].
  • Department of Health and Human Services (US), Centers for Medicare & Medicaid Services. Fed Regist. 2004 Jan 23;69(15):3434–69.

  • Centers for Medicare & Medicaid Services (US). [Internet]. Baltimore (MD): CMS; [cited 2026 Jun 16].

  • Centers for Medicare & Medicaid Services (US). [Internet]. Baltimore (MD): CMS; [cited 2026 Jun 16].

  • Centers for Medicare & Medicaid Services (US). [Internet]. Baltimore (MD): CMS; 2026 [cited 2026 Jun 16].

  • Data Access

    References

    Resources

    Articles

    Links

    [3]
    [4]
    [6]
    [7]
    [7]
    [6]
    [6]
    [6]
    [6,8]
    NPI fact sheet: guidance on subpart determination for Medicare organization providers who are covered entities under HIPAA
    NPIs — National Provider Identifiers
    National Plan and Provider Enumeration System — privacy impact assessment (PIA)
    Using the National Provider Identifier for health care workforce evaluation.
    NPIs — National Provider Identifiers | CMS
    Data Dissemination | CMS
    NPI Registry API
    NPPES data dissemination — code values
    HIPAA administrative simplification: standard unique health identifier for health care providers; final rule.
    Data dissemination
    NPI Registry
    NPPES NPI files
    NPPES NPI downloadable files

    Code Values

    Allowed values for coded fields. Source: CMS NPPES Code Values, February 1, 2025.

    1. Entity Type Code

    Code
    Description

    1

    Individual

    2

    Organization

    2. Sole Proprietor

    Code
    Description
    Code
    Description
    Code
    Description
    Code
    Description
    Code
    Description
    Code
    Description
    Code
    Description
    Code
    Description
    Code
    Description
    Code
    Description

    Healthcare Cost and Utilization Project (HCUP)

    Overview

    The Healthcare Cost and Utilization Project (HCUP) is a family of databases, software tools, and related products developed through a Federal-State-Industry partnership and sponsored by the Agency for Healthcare Research and Quality (AHRQ). HCUP databases are derived from administrative data and contain encounter-level, clinical, and nonclinical information including all-listed diagnoses and procedures, discharge status, patient demographics, and charges for all patients, regardless of payer, beginning in 1988. [1]

    HCUP offers the following databases:

    • National (Nationwide) Inpatient Sample (NIS): largest publicly available all-payer hospital inpatient care database in the United States

    • Kids' Inpatient Database (KID): hospital inpatient stays for children and is specifically designed to allow researchers to study a broad range of conditions and procedures related to children's health

    • Nationwide Emergency Department Sample (NEDS): emergency department (ED) visits that do not result in an admission as well as ED visits that result in an admission to the same hospital

    • Nationwide Readmissions Database: designed to support various types of analyses of national readmission rates for all payers and uninsured individuals

    • State Inpatient Databases (SID): inpatient discharge abstracts from participating States, translated into a uniform format to facilitate multi-State comparisons and analyses

    • State Ambulatory Surgery and Services Databases (SASD): encounter-level data for ambulatory surgery and other outpatient services from hospital-owned facilities

    • State Emergency Department Databases (SEDD): discharge information on all emergency department visits that do not result in an admission

    Please note: Access to HCUP databases is not free. Database releases must be purchased through the .

    Visit for a more information about the databases. Learn more about HCUP on the .

    1. Agency for Healthcare Research and Quality. (n.d.). . Retrieved May 1, 2024.

    Health Data Partners

    Below is a list of current Health Data Partners (HDPs) engaged with the URSA Initiative.

    To learn more about requesting data from any of these HDPs, please submit the Advance RI-CTR Service Request Form.

    Brown University Health

    Since March 2015, Brown University Health has used LifeChart built on the Epic EHR platform. There are a variety of reporting and analytic tools, such as SlicerDicer and Reporting Workbench, which can be used within Brown University Health. Reports or data extracts can also be requested.

    Care New England

    Care New England uses the Epic and Cerner electronic health record (EHR) systems for outpatient and inpatient respectively. Both systems have a suite of reporting and analytic tools for use within the health systems. Reports and data extracts can also be requested.

    Rhode Island Department of Health

    The Rhode Island Department of Health supports and maintains a range of health datasets and systems that can be used for research.

    (RI APCD or HealthFacts RI) is a large-scale database that systematically collects healthcare claims data from a variety of payer sources, including Medicare, Medicaid, and RI’s nine largest commercial payers.

    Founded in 2001, the Rhode Island Quality Institute (RIQI) is the state-designated Regional Health Information Organization (RHIO). RIQI manages , Rhode Island’s state-designated Health Information Exchange (HIE). CurrentCare contains EHR and health data from all acute care hospital systems in Rhode Island and from many ambulatory and laboratory facilities across the state. RIQI has provided public health and research data to external partners such as the Rhode Island Department of Health and Brown University. More information about the data in CurrentCare can be found in the .

    Synthea Modules Used in the Generation of SyntheticRI 2026

    Module
    Category

    SyntheticRI 2026: Synthetic Healthcare Records for Rhode Island

    The SyntheticRI 2026 datasets consist of patient-centric synthetic health records representing the population of Rhode Island. The data was generated using Synthea™, an open-source simulation framework that models the clinical journey of synthetic patients from birth to death. The primary objective of these datasets is to provide a realistic environment for healthcare research, software development, and clinical informatics training.

    These datasets contains no real-world patient data. Because all individuals and clinical events are computationally generated from the ground up, the records are entirely free of personally identifiable information (PII). This allows for unrestricted sharing and analysis in compliance with HIPAA and GDPR standards.

    To use these datasets for educational or reseach purposes, please contact bcbi@brown.edu

    The patient population and their respective health trajectories were simulated using the Synthea™ generator (Walonoski et al., 2018). The simulation utilizes a modular, logic-based approach where clinical outcomes are driven by transition-based state machines.

    Demographics: Patient demographics, including age, gender, race, and socio-economic status, are statistically aligned with the United States Census Bureau data for the state of Rhode Island to ensure regional representativeness.

    X

    Undisclosed

    Other

    Other reason

    4

    Former Legal Business Name — Organization

    5

    Other Name — Both

    Mrs.

    Mrs.

    Dr.

    Dr.

    Prof.

    Prof.

    II

    II

    III

    III

    IV

    IV

    V

    V

    VI

    VI

    VII

    VII

    VIII

    VIII

    IX

    IX

    X

    X

    Y

    Yes — the individual is a sole proprietor

    N

    No — not a sole proprietor

    X

    Not answered

    Y

    Yes — the organization is a subpart

    N

    No — not a subpart

    X

    Not answered

    M

    Male

    F

    Female

    U

    Undisclosed

    Death

    Provider is deceased

    Disbandment

    Organization has disbanded

    Fraud

    NPI was obtained fraudulently

    1

    Former Name — Individual

    2

    Professional Name — Individual

    3

    Doing Business As — Organization

    Ms.

    Ms.

    Mr.

    Mr.

    Miss

    Miss

    Jr.

    Jr.

    Sr.

    Sr.

    I

    I

    Y

    Yes — primary taxonomy (only one per NPI)

    N

    No — not the primary taxonomy

    X

    Not answered

    193200000X

    Multi-Specialty Group — practitioners with different specializations

    193400000X

    Single Specialty Group — practitioners with the same specialization

    1

    Other

    5

    Medicaid

    —

    Note: legacy values (02 Medicare UPIN, 04 Medicare ID, 06 BCBS, 07 Medicare PIN) may appear in older records.

    3. Organization Subpart

    4. Sex Code

    5. NPI Deactivation Reason

    6. Other Provider Name Type

    7. Name Prefix

    8. Name Suffix

    9. Primary Taxonomy Switch

    10. Group Taxonomy

    11. Other Provider Identifier Type

    References

    Resources

    Links

    Online HCUP Central Distributor
    AHRQ HCUP
    HCUP website
    Healthcare Cost and Utilization Project (HCUP)
    HCUP Website
    HCUP Databases

    The Rhode Island Quality Institute

    Rhode Island’s All-Payer Claims Database
    CurrentCare
    Data Analytics and Reporting
    CurrentCare Data Guide

    Immunology & Allergy

    Anemia - Unknown Etiology

    Hematology

    Appendicitis

    Gastroenterology

    Asthma

    Pulmonology

    Atopy

    Immunology & Allergy

    Atrial Fibrillation

    Cardiology

    Attention Deficit Disorder

    Neurology

    Bone Marrow Transplant

    Oncology

    Breast Cancer

    Oncology

    Bronchitis

    Pulmonology

    Cerebral Palsy

    Neurology

    Chronic Kidney Disease

    Nephrology

    Colorectal Cancer

    Oncology

    Congestive Heart Failure

    Cardiology

    Contraceptive Maintenance

    Reproductive Health

    Contraceptives

    Reproductive Health

    COPD

    Pulmonology

    Covid19

    Infectious Disease

    Cystic Fibrosis

    Pulmonology

    Dementia

    Neurology

    Dental and Oral Examination

    Dental

    Dentures

    Dental

    Diabetic Retinopathy Treatment

    Ophthalmology

    Dialysis

    Nephrology

    Ear Infections

    Infectious Disease

    Epilepsy

    Neurology

    Female Reproduction

    Reproductive Health

    Fibromyalgia

    Rheumatology & Musculoskeletal

    Food Allergies

    Immunology & Allergy

    Gallstones

    Gastroenterology

    Gout

    Rheumatology & Musculoskeletal

    HIV Care

    Infectious Disease

    HIV Diagnosis

    Infectious Disease

    Home Heatlh Treatment

    Health Services & Social Determinants

    Home Hospice SNF

    Health Services & Social Determinants

    Homelessness

    Health Services & Social Determinants

    Hospice Treatment

    Health Services & Social Determinants

    Hypertension

    Cardiology

    Hypothyroidism

    Endocrinology & Metabolism

    Injuries

    Trauma & Emergency

    Kidney Transplant

    Nephrology

    Lung Cancer

    Oncology

    Lupus

    Rheumatology & Musculoskeletal

    Veteran Mild TBI

    Neurology

    Medication Reconciliation

    Health Services & Social Determinants

    MEND Program

    Endocrinology & Metabolism

    Metabolic Syndrome Standards of Care

    Endocrinology & Metabolism

    Metabolic Syndrome Disease Progresion

    Endocrinology & Metabolism

    Myocardial Infarction

    Cardiology

    Opiod Addiction

    Substance Abuse

    Osteoarthritis

    Rheumatology & Musculoskeletal

    Osteoporosis

    Rheumatology & Musculoskeletal

    Pregnancy

    Reproductive Health

    Prescribing Optiods for Chronic Pain and Treatmebt of OUD

    Substance Abuse

    Rheumatoid Arthritis

    Rheumatology & Musculoskeletal

    Self Harm

    Behavioral Health & Psychiatry

    Sepsis

    Infectious Disease

    Sexual Activity

    Reproductive Health

    Sinusitis

    Pulmonology

    Sleep Apnea

    Pulmonology

    Sore Throat

    Infectious Disease

    Spina Bifida

    Neurology

    Stable Ischemic Heart Disease

    Cardiology

    Stroke

    Cardiology

    Total Joint Replacement

    Rheumatology & Musculoskeletal

    Trigger Bone Marrow Transplant

    Oncology

    Urinary Tract Infections

    Infectious Disease

    Veteran

    Health Services & Social Determinants

    Veteran Hyperlipidemia

    Cardiology

    Veteran Lung Cancer

    Oncology

    Veteran MDD

    Behavioral Health & Psychiatry

    Veteran Prostate Cancer

    Oncology

    Veteran PTSD

    Behavioral Health & Psychiatry

    Veteran Self Harm

    Behavioral Health & Psychiatry

    Veteran Substance Abuse Conditions

    Substance Abuse

    Veteran Substance Abuse Treatment

    Substance Abuse

    VHD Aortic

    Cardiology

    VHD Mitral

    Cardiology

    VHD Pulmonic

    Cardiology

    VHD Tricuspid

    Cardiology

    Wellness Encounters

    Health Services & Social Determinants

    Acute Myeloid Leukemia for PCOR Research

    Oncology

    Allergic Rhinitis

    Immunology & Allergy

    Allergies and Treatment

    Clinical Logic: Disease progression, treatment pathways, and clinical encounters are dictated by over 80 validated clinical modules. These modules are developed based on peer-reviewed clinical guidelines and public health statistics from sources such as the CDC, NIH, and various specialty medical associations.

    The commands used to generate these datasets, including the specific seed, are as follows:

    SyntheticRI records include codes from the following vocabularies:

    • Conditions and Diagnoses: SNOMED-CT (Systematized Nomenclature of Medicine – Clinical Terms)

    • Observations and Vitals: LOINC (Logical Observation Identifiers Names and Codes)

    • Medications: RxNorm

    • Vaccines: CVX (Clinical Vaccine) codes

    • Walonoski, J., Klaus, M., Granger, E., Hall, D., Gregorowicz, A., Neyarapally, G., Watson, A., & McLachlan, J. (2018). Synthea: An approach, method, and software mechanism for generating synthetic electronic health records. Journal of the American Medical Informatics Association, 25(3), 230–238.

    • Synthea Documentation & Wiki: Synthetic Health Research. (n.d.). Synthea Wiki.

    • Source Code: Synthetic Health. (2024). Synthea Patient Population Simulator.

    Overview

    Methodology and Generation

    Standardized Healthcare Vocabularies

    Resources

    Articles

    Links

    ./run_synthea -s 20260508 -p 1000 "Rhode Island"
    ./run_synthea -s 20260508 -p 300000 "Rhode Island"

    MIMIC-IV

    Overview

    The Medical Information Mart for Intensive Care (MIMIC) is a publicly available repository of deidentified electronic health record (EHR) data from patients admitted to the Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. This resource was created in collaboration with Massachusetts Institute of Technology to lower barriers to reproducible clinical research by making real world hospital data accessible in a deidentified form.

    MIMIC is organized into four datasets, which altogether contain five modules. The following info pertain to their latest versions:

    MIMIC-IV (version 3.1): This dataset contains info derived from 2008-2022.

    • The Hosp module contains hospital-level tables related to 546,028 hospitalizations for 223,452 unique individuals.

    • The ICU module is for for intensive care unit admissions and contains 94,458 ICU stays for 65,366 unique individuals

    MIMIC-IV-ED (version 2.2):

    • The ED module contains tables related to emergency department (ED) visits from 2011 to 2019. There are 425,087 ED visits of which 203,016 led to hospital admissions.

    MIMIC-IV-Note (version 2.2):

    • The Note module contains tables related to 331,794 deidentified discharge summaries from 145,915 patients admitted to the hospital and emergency department.

    MIMIC-CXR (latest version 2.0) :

    • The CXR module contains tables related to 377,110 images corresponding to 227,835 radiographic studies in Digital Imaging and Communications in Medicine (DICOM) format with free text radiology reports made in the emergency department from 2011 to 2016

    Other notable modules include the following:

    • The ECG module contains approximately 800,000 diagnostic electrocardiograms from nearly 160,000 unique patients. These diagnostic ECGs use 12 leads, are 10 seconds in length and are sampled at 500 Hz.

    • The ECHO module contains 206,488 echocardiogram studies (including 179,928 transthoracic, 16,389 stress, and 10,171 transesophageal echocardiograms) from 91,372 unique patients between 2008 and 2022.

    • The MIMIC-IV-ECHO module contains structured echocardiographic measurements and DICOM files from echocardiography exams.

    Data across the MIMIC-IV family were sourced from Beth Israel Deaconess Medical Center's (BIDMC) systems, with each component drawn from their respective sources. For instance, MIMIC-IV Core drew from the hospital-wide EHR and ICU bedside systems, excluding patients under 18 at first visit or on an enhanced-protection list; MIMIC-IV-Note included only notes within one year of a hospital or ED encounter; MIMIC-IV-ED drew emergency department records in XML format; and MIMIC-CXR separately sourced chest radiograph studies via the local EHR and Radiology Information System (RIS), alongside their associated free-text reports.

    Raw data were converted into structured, analysis-ready formats while preserving the integrity of the original clinical record. MIMIC-IV was transformed via custom SQL into a schema organized into the Hosp and ICU modules, designed for backward compatibility with MIMIC-III, with tables exported as CSV files and no data cleaning applied so the dataset reflects real-world clinical data as recorded. Out-of-hospital deaths were linked to Massachusetts state vital records using a custom workflow combining exact and fuzzy matching (name, date of birth, social security number), prioritizing sensitivity over specificity. MIMIC-IV-ED's XML extracts were converted into a denormalized relational database to support analysis. MIMIC-CXR integrated three separately processed streams into a single unified dataset: EHR data, DICOM-format imaging, and extracted radiology reports (stripped of administrative/clinical metadata).

    All datasets meet HIPAA Safe Harbor requirements, though each applies methods suited to its data type. Structured data across MIMIC-IV, MIMIC-IV-ED, and MIMIC-CXR had direct identifiers removed and replaced with randomly assigned IDs (subject_id, hadm_id, stay_id) that remain consistent across datasets to enable cross-linkage. Dates were shifted using patient-specific offsets to preserve within-patient chronological relationships. Free-text and unstructured data required additional handling: MIMIC-IV-Note and MIMIC-CXR's radiology reports were deidentified using a combination of rule-based methods, a purpose-built neural network, and manual review; MIMIC-IV-ED's free-text fields were scrubbed and replaced with placeholders; and MIMIC-CXR's DICOM imaging had PHI removed from both metadata and pixel data via a custom algorithm with manual validation. Finally, released datasets were exported in a character-based, comma-delimited format for distribution.

    The MIMIC team provides and maintains code in the public mimic-code repository () to generate tables and common variables such as severity scores to make analysis easier.

    Access to MIMIC is provided via Physionet and restricted. For Brown University staff and students, access can be provided on OSCAR after meeting the following requirements. Researchers generally need to be credentialed, complete human subjects training via CITI courses and sign a data use agreement before obtaining the full dataset. For more detailed instructions, please refer to your Primary Investigator or Brown faculty.

    • ICD-9-CM diagnoses

    • ICD-9-PCS procedures

    • ICD-10-CM diagnoses

    • ICD-10-PCS procedures

    • National Drug Code (NDC)

    • Logical Observation Identifiers, Names and Codes(LOINC)

    • DICOM

    1. , Pub. L. No. 104-191.

    • Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, Pollard TJ, Hao S, Moody B, Gow B, Lehman LH, Celi LA, Mark RG. Sci Data. 2023 Jan 3;10(1):1. doi: 10.1038/s41597-022-01899-x. Erratum in: Sci Data. 2023 Jan 16;10(1):31. doi: 10.1038/s41597-023-01945-2. Erratum in: Sci Data. 2023 Apr 18;10(1):219. doi: 10.1038/s41597-023-02136-9. PMID: 36596836; PMCID: PMC9810617.

    • Johnson AEW, Pollard TJ, Berkowitz SJ, Greenbaum NR, Lungren MP, Deng CY, Mark RG, Horng S. Sci Data. 2019 Dec 12;6(1):317. doi: 10.1038/s41597-019-0322-0. PMID: 31831740; PMCID: PMC6908718.

    • Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng CK, Stanley HE. Circulation. 2000 Jun 13;101(23):E215-20. doi: 10.1161/01.cir.101.23.e215. PMID: 10851218.

    Data Dictionary

    Data Dictionary

    cBioPortal for Cancer Genomics

    Unless otherwise noted, information in this overview is adapted from the official cBioPortal documentation at docs.cbioportal.org. See references.

    The cBioPortal for Cancer Genomics is an open-access, open-source platform for the interactive exploration of multidimensional cancer genomics datasets with an emphasis on multimodal cancer visualization. This resource aims to significantly lower the barriers between complex genomic data and cancer researchers by providing rapid, intuitive, and high-quality access to molecular profiles and clinical attributes from large-scale cancer genomics projects, empowering researchers, clinicians, and translational scientists to extract biological insights and create clinical applications from these rich datasets. cBioPortal provides visualization, analysis, and download from a wide range of datasets predominantly sourced from The Cancer Genome Atlas, with a growing number of institutional and consortium cohorts added over time. Data types span somatic mutations, structural variants and gene fusions, copy number alterations, mRNA and microRNA expression, DNA methylation, and protein/phosphoprotein levels (RPPA), with samples also linked to clinical and treatment attributes. The platform was originally developed at Memorial Sloan Kettering Cancer Center and is now maintained by a multi-institutional team consisting of MSK, the Dana-Farber Cancer Institute, Princess Margaret Cancer Centre, Children's Hospital of Philadelphia, Caris Life Sciences, The Hyve, SE4BIO, and Bilkent University.

    cBioPortal was developed to address the data-integration challenges posed by large-scale cancer genomics projects, making raw data from these efforts more easily and directly available to the cancer research community, supporting both basic and translational research. Each study loaded into the portal is built from a standardized set of source files (clinical data tables, mutation files, copy-number segment files, expression matrices, etc.) that are validated and harmonized before import. cBioPortal generally does not generate primary experimental data; it hosts, curates, annotates, harmonizes, and visualizes data generated by external projects, consortia, publications, or institutional pipelines.

    Behavioral Risk Factor Surveillance System (BRFSS)

    The Behavioral Risk Factor Surveillance System (BRFSS) was established in 1984 by the U.S. Centers for Disease Control and Prevention (CDC) to collect prevalence data regarding risk behaviors and preventive health practices among adult residents across all 50 states, the District of Columbia, and participating U.S. territories. The state-based, cross-sectional telephone survey was conducted monthly by state health departments. The survey has consisted of standard core questions on emerging health issues, rotating core questions asked every other year, optional modules, and state-added questions on health priorities specific to the respective state. Collected data was processed through editing, weighting, and analysis to provide critical information on health status. The BRFSS aims to inform the management of health-related policies and priorities at both the state and national levels. Published data, reports, questionnaires, and analysis tools are publicly accessible through the CDC BRFSS website. Data files are provided in ASCII (fixed record length) and SAS Transport (.XTP) formats.

    The BRFSS dataset was created using a standardized questionnaire developed in collaboration between the CDC and U.S. state health departments. The survey consisted of a standard core, rotating core, and optional modules. Data was collected by states or private contractors following CDC protocols, which included multiple call attempts and specific schedules to ensure representative participation on weeknights and weekends. The sampling design utilized disproportionate stratified sampling (DSS) for landlines to increase the efficiency of finding residential numbers and a randomly generated frame for cellular phones. The collected data underwent design weighting–which adjusts for the number of adults and telephones in a household–followed by iterative proportional fitting–which aligns the sample with population demographics like age, sex, race, education, and phone ownership to ensure the final results are representative of the population.

    HCPCS

  • MIMIC-CXR Physionet Page

  • MIMIC-IV-ED Physionet Page

  • MIMIC-IV-Note Physionet Page

  • MIMIC-IV-ECG Physionet Page

  • MIMIC-IV-ECHO Physionet Page

  • MIMIC-IV Datasets in Oscar

  • DICOM standard

  • Studies that have utilized MIMIC-IV on PubMed

  • MIMIC-IV-ECG

    MIMIC-IV-ECHO

    Methodology and Generation

    Acquisition

    Transformation

    Deidentification

    Derived tables

    Data Access

    Standardized Healthcare Vocabularies

    Diagnoses and Procedures

    Medications

    Labs

    Imaging

    References

    Resources

    Articles

    Links

    http://github.com/MIT-lcp/mimic-code
    Health Insurance Portability and Accountability Act [HIPAA] of 1996
    CDC ICD-10-CM Browser Tool
    WHO ICD-10 CM Site
    ICD 9-CM Look up Site
    MIMIC-IV, a freely accessible electronic health record dataset.
    MIMIC-CXR, a de-identified publicly available database of chest radiographs with free-text reports.
    PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals.
    MIMIC-IV v3.1 Physionet Page
    MIMIC-IV Physionet Search Page for all module related info
    MIMIC MIT website
    MIMIC Code Repository

    N/A

    Q2

    18-18

    What is your sex?

    1=Female; 2=Male

    N/A

    Q3

    19-19

    In what grade are you?

    1=9th; 2=10th; 3=11th; 4=12th; 5=Other

    N/A

    Q4

    20-20

    Are you Hispanic or Latino?

    1=Yes; 2=No

    N/A

    Q5

    21-28

    What is your race?

    A=Am. Indian; B=Asian; C=Black; D=Native Hawaiian; E=White

    N/A

    Variable Name

    Data Location

    Question Text / Label

    Value Codes & Labels

    Response of Interest (ROI)

    Q6

    29-32

    Height (meters)

    Continuous (from feet/inches)

    Variable Name

    Data Location

    Question Text / Label

    Value Codes & Labels

    Response of Interest (ROI)

    Q8

    39-39

    Seat belt use

    1=Never; 2=Rarely; 3=Sometimes; 4=Most of the time; 5=Always

    Variable Name

    Data Location

    Question Text / Label

    Value Codes & Labels

    Response of Interest (ROI)

    Q12

    43-43

    Carried weapon (school)

    1=0 days; 2=1 day; 3=2-3; 4=4-5; 5=6+

    Variable Name

    Data Location

    Question Text / Label

    Value Codes & Labels

    Response of Interest (ROI)

    Q31

    62-62

    Ever smoked a cigarette

    1=Yes; 2=No

    Variable Name

    Data Location

    Question Text / Label

    Value Codes & Labels

    Response of Interest (ROI)

    Q56

    87-87

    Ever had sexual intercourse

    1=Yes; 2=No

    Variable Name

    Data Location

    Question Text / Label

    Value Codes & Labels

    Response of Interest (ROI)

    QNOBESE

    386-386

    % with obesity

    1=Yes; 2=No

    Variable Name

    Data Location

    Question Text / Label

    Value Codes & Labels

    Response of Interest (ROI)

    WEIGHT

    388-397

    Weight factor

    Continuous decimal

    Variable Name

    Data Location

    Question Text / Label

    Value Codes & Labels

    Response of Interest (ROI)

    Q1

    17-17

    How old are you?

    1. Demographics

    1=12 or younger; 2=13; 3=14; 4=15; 5=16; 6=17; 7=18 or older

    2. Physical Metrics

    3. Safety Behaviors

    4. Violence & Suicide

    5. Substance Use

    6. Sexual Behaviors

    7. Health Outcomes

    8. Analysis

    IDATE

    Date Interview Completed

    Char

    MMDDYYYY

    Variable Name

    Variable Label / Question Text

    Type

    Values & Labels

    SEXVAR

    Sex of Respondent

    Num

    1=Male; 2=Female

    Variable Name

    Variable Label / Question Text

    Type

    Values & Labels

    _BMI5

    Body Mass Index (BMI)

    Num

    Continuous (4 decimal places)

    Variable Name

    Variable Label / Question Text

    Type

    Values & Labels

    _STSTR

    Sample Design Stratification Variable

    Num

    Internal Code (used for variance)

    Variable Name

    Variable Label / Question Text

    Type

    Values & Labels

    _RFHLTH

    Adults with good or better health

    Num

    1=Good/Better; 2=Fair/Poor

    Variable Name

    Variable Label / Question Text

    Type

    Values & Labels

    _STATE

    State FIPS Code

    Num

    1=Alabama; 2=Alaska... 72=PR

    1. Identifiers

    2. Demographics

    3. Clinical Metrics

    4. Complex Design

    5. Disposition

    Data in cBioPortal is organized into studies, each of which includes a study description file, clinical meta file, and a clinical data file. Before any study can be loaded into cBioPortal, all files must pass a validation phase to ensure they are following the correct content and formatting guidelines. Studies can be loaded incrementally for certain data types without re-uploading an entire study, and datasets that are subsets or combinations of existing studies can be represented as virtual studies to avoid duplication. For further information on how to load or download study data see the links section below.

    cBioPortal does not enforce a standardized clinical ontology across studies for patient and sample attributes. Instead, study authors of the published studies determine the organization of their clinical data. Although cBioPortal does not require a universal clinical ontology across studies, several standardized conventions are used for genomic data to support harmonization and cross-study analyses.

    • OncoTree (cancer type taxonomy) — used as the hierarchical cancer classification system underlying cBioPortal. Each study specifies a type_of_cancer value, which maps to the portal's cancer type hierarchy; custom cancer type definitions can also be supplied when loading a study.

    • Reference genome assemblies (hg19/GRCh37, hg38/GRCh38) — genomic datasets specify the reference genome assembly used for sequence alignment and genomic coordinates through study metadata (e.g., reference_genome). Segmented copy-number datasets additionally specify a reference_genome_id field to ensure consistent interpretation of genomic locations.

    • TCGA Mutation Annotation Format (MAF) — provides the standardized file format and controlled Variant_Classification values (e.g., Missense_Mutation, Nonsense_Mutation, Splice_Site) used for importing somatic mutation data.

    • HGVS (Human Genome Variation Society) nomenclature — used for standardized reporting of sequence and protein variants, including amino acid changes associated with genomic mutations.

    • HUGO Gene Nomenclature Committee (HGNC) gene symbols — standardized gene symbols used in genomic datasets through the Hugo_Symbol field.

    • NCBI Entrez Gene identifiers — stable numeric gene identifiers used through the Entrez_Gene_Id field. Depending on the data type, cBioPortal accepts HGNC symbols, Entrez Gene identifiers, or both to support consistent gene mapping across studies.

    For further information see the Links section below.

    Demographic information is limited to just AGE and SEX/GENDER with native platform support. Other standard demographic fields are not enforced and vary by study/what the author chooses to include. There are no platform-wide demographic charactersitics published by cBioPortal. At the individual study level: demographic data including race and age IS displayed in Study View, but only when the contributing study authors included it in their clinical data file.

    cBioPortal for Cancer Genomics. Overview [Internet]. New York (NY): Memorial Sloan Kettering Cancer Center; 2026 [cited 2026 Jul 15]. Available from: https://docs.cbioportal.org/user-guide/overview/

    • Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4. doi: 10.1158/2159-8290.CD-12-0095. Erratum in: Cancer Discov. 2012 Oct;2(10):960. PMID: 22588877; PMCID: PMC3956037.

    • Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1. doi: 10.1126/scisignal.2004088. PMID: 23550210; PMCID: PMC4160307.

    • de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, Li X, Ochoa A, Zhao G, Lai B, Abeshouse A, Baiceanu D, Ciftci E, Dogrusoz U, Dufilie A, Erkoc Z, Garcia Lara E, Fu Z, Gross B, Haynes C, Heath A, Higgins D, Jagannathan P, Kalletla K, Kumari P, Lindsay J, Lisman A, Leenknegt B, Lukasse P, Madela D, Madupuri R, van Nierop P, Plantalech O, Quach J, Resnick AC, Rodenburg SYA, Satravada BA, Schaeffer F, Sheridan R, Singh J, Sirohi R, Sumer SO, van Hagen S, Wang A, Wilson M, Zhang H, Zhu K, Rusk N, Brown S, Lavery JA, Panageas KS, Rudolph JE, LeNoue-Newton ML, Warner JL, Guo X, Hunter-Zinck H, Yu TV, Pilai S, Nichols C, Gardos SM, Philip J; AACR Project GENIE BPC Core Team, AACR Project GENIE Consortium; Kehl KL, Riely GJ, Schrag D, Lee J, Fiandalo MV, Sweeney SM, Pugh TJ, Sander C, Cerami E, Gao J, Schultz N. Cancer Res. 2023 Dec 1;83(23):3861-3867. doi: 10.1158/0008-5472.CAN-23-0816. PMID: 37668528; PMCID: PMC10690089.

    • cBioPortal Tutorial Slides

    • cBioPortal Data Loading Documentation

    • cBioPortal File Formats Documentation

    Overview

    Methodology and Generation

    Standardized Healthcare Vocabularies

    Demographics

    References

    Resources

    Articles

    Links

    Standardized queries asked by all states either annually or every other year to ensure consistent national data.

    Derived clinical and behavioral metrics, such as Body Mass Index (BMI), which are identifiable in the dataset by a preceding underscore (ie. _BMI).

    Specific internal codes including final weight for combined landline/cellular data (_LLCPWT) and stratum weight (_STRWT) used for complex sampling analysis.

    Standardized variables for stratification (_STSTR) and clustering (_PSU) required for proper analysis in statistical software.

    Standardized result codes (ie. completed interview, refusal, ineligible) established by the American Association of Public Opinion Research (AAPOR) to calculate response and cooperation rates.

    Standardized categories for reporting age, race, ethnicity, marital status, education level, and home ownership.

    1. U.S. Centers for Disease Control and Prevention. The BRFSS Data User Guide June 2013 [Internet]. Aug 15, 2013.

    2. U.S. Centers for Disease Control and Prevention. BRFSS Overview 2024 [Internet]. 2025.

    3. U.S. Centers for Disease Control and Prevention. 2024 BRFSS Survey Data and Documentation [Internet]. 2025.

    • Gundersen DA, ZuWallack RS, Dayton J, Echeverría SE, Delnevo CD. Assessing the Feasibility and Sample Quality of a National Random-digit Dialing Cellular Phone Survey of Young Adults. Am J Epidemiol. 2014 Jan 1;179(1):39–47. doi:10.1093/aje/kwt226 PubMed PMID: 24100957; PubMed Central PMCID: PMC3864711.

    • Hsia J, Zhao G, Town M, Ren J, Okoro CA, Pierannunzi C, et al. Comparisons of Estimates From the Behavioral Risk Factor Surveillance System and Other National Health Surveys, 2011−2016. American Journal of Preventive Medicine. 2020 Jun 1;58(6):e181–90. doi:10.1016/j.amepre.2020.01.025 PubMed PMID: 32444008.

    • Hu SS, Pierannunzi C, Balluz L. Integrating a Multimode Design Into a National Random-Digit–Dialed Telephone Survey. Prev Chronic Dis. 2011 Oct 15;8(6):A145. PubMed PMID: 22005638; PubMed Central PMCID: PMC3221584.

    • Li C, Balluz LS, Ford ES, Okoro CA, Zhao G, Pierannunzi C. . Preventive Medicine. 2012 Jun 1;54(6):381–7. doi:10.1016/j.ypmed.2012.04.003

    • Pierannunzi C, Hu SS, Balluz L. . BMC Med Res Methodol. 2013 Mar 24;13(1):49. doi:10.1186/1471-2288-13-49

    • CDC BRFSS Survey Data & Documentation

    • CDC BRFSS Questionnaires

    Overview

    Methodology and Generation

    Standardized Healthcare Vocabularies

    Standard and Core Questions

    Calculated Variables

    Variable Weights

    Complex Sampling Identifiers

    AAPOR Disposition Codes

    Demographic Labels

    References

    Resources

    Articles

    Links

    N/A

    Q7

    33-38

    Weight (kilograms)

    Continuous (from pounds)

    N/A

    N/A

    QN8

    185-185

    % did not always wear seat belt

    1=Yes; 2=No

    1 (Answers A,B,C,D to Q8)

    Q9

    40-40

    Rode with drinking driver

    1=0 times; 2=1 time; 3=2-3; 4=4-5; 5=6+

    N/A

    QN9

    186-186

    % rode with drinking driver

    1=Yes; 2=No

    1 (Answers B,C,D,E to Q9)

    Q10

    41-41

    Drove after drinking

    1=Did not drive; 2=No; 3=1 time; 4=2-3; 5=4-5; 6=6+

    N/A

    QN10

    187-187

    % drove after drinking

    1=Yes; 2=No

    1 (Answers C,D,E,F to Q10)

    N/A

    QN12

    189-189

    % carried weapon (school)

    1=Yes; 2=No

    1 (Answers B,C,D,E to Q12)

    Q26

    57-57

    Sad or hopeless (2+ weeks)

    1=Yes; 2=No

    N/A

    QN26

    203-203

    % felt sad or hopeless

    1=Yes; 2=No

    1 (Answer A to Q26)

    Q27

    58-58

    Seriously considered suicide

    1=Yes; 2=No

    N/A

    QN27

    204-204

    % considered suicide

    1=Yes; 2=No

    1 (Answer A to Q27)

    N/A

    QN31

    208-208

    % ever smoked

    1=Yes; 2=No

    1 (Answer A to Q31)

    Q35

    66-66

    Ever used electronic vapor

    1=Yes; 2=No

    N/A

    QN35

    212-212

    % ever used vapor product

    1=Yes; 2=No

    1 (Answer A to Q35)

    Q43

    73-73

    Binge drinking (past 30 days)

    1=0 days; 2=1; 3=2; 4=3-5; 5=6-9; 6=10-19; 7=20+

    N/A

    QN43

    220-220

    % currently binge drinking

    1=Yes; 2=No

    1 (Answers B,C,D,E,F,G to Q43)

    Q46

    77-77

    Ever used marijuana

    1=0 times; 2=1-2; 3=3-9; 4=10-19; 5=20-39; 6=40-99; 7=100+

    N/A

    QN46

    223-223

    % ever used marijuana

    1=Yes; 2=No

    1 (Answers B,C,D,E,F,G to Q46)

    N/A

    QN56

    233-233

    % ever had sex

    1=Yes; 2=No

    1 (Answer A to Q56)

    Q61

    92-92

    Used condom last time

    1=Never sex; 2=Yes; 3=No

    N/A

    QN61

    238-238

    % used condom last time

    1=Yes; 2=No

    1 (Answer B to Q61)

    1 (>= 95th percentile BMI)

    QNOWT

    387-387

    % overweight

    1=Yes; 2=No

    1 (>= 85th and < 95th % BMI)

    RACEETH

    414-415

    Standardized Race/Ethnicity

    1=Am Indian; 2=Asian; 3=Black; 5=White; 6=Hispanic

    N/A

    N/A

    STRATUM

    398-400

    Stratum identifier

    Continuous

    N/A

    PSU

    401-406

    Primary Sampling Unit

    Continuous

    N/A

    _AGEG5TYP

    Five-year age group (calculated)

    Num

    1=18-24; 2=25-29... 13=80+

    _RACE

    Calculated Race/Ethnicity Category

    Num

    1=White; 2=Black; 8=Hispanic

    _BMI5CAT

    BMI Category

    Num

    1=Underweight; 2=Normal; 3=Overweight; 4=Obese

    _PSU

    Primary Sampling Unit

    Num

    Internal Code (used for clustering)

    _LLCPWT

    Final Weight: Landline and Cell Phone

    Num

    Continuous (Statistical weight)

    _STRWT

    Stratum Weight

    Num

    Continuous (Statistical weight)

    DISPCODE

    Final Disposition Code

    Num

    110=Complete; 120=Partial

    Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal.
    A comparison of prevalence estimates for selected health indicators and chronic diseases or conditions from the Behavioral Risk Factor Surveillance System, the National Health Interview Survey, and the National Health and Nutrition Examination Survey, 2007–2008
    A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004–2011

    DailyMed SPL Dataset

    Overview

    The DailyMed Full SPL Dataset refers to the downloadable full release of all drug labels in the United States. The dataset is hosted by the National Library of Medicine of the National Institute of Health (NIH). There are five subsets of drug labels available as full SPL releases: human prescription labels, human over-the-counter (OTC) labels, homeopathic labels, animal labels, and remaining labels.

    Methodology and Generation

    Pharmaceutical companies are required to submit a standard product label (SPL) to the Food and Drug Administration (FDA). SPLs are typically encoded in XML format, standardized by the Health Level Seven International (HL7) schema to ensure the labels are organized and machine readable. This includes the tagging of various sections within the label using Logical Observation Identifiers Names and Codes (LOINC®). After submission to the FDA, labels are stored by the National Library of Medicine, which makes all SPLs available for download via DailyMed.

    Access and Analysis

    Accessing the Full SPL release through DailyMed is completely free and does not require an account. Downloading the largest of the datasets requires at least 16.38GB of space on the user’s device. To download, navigate to the DailyMed website, then click “Download Data” under the header NLM SPL Resources. The page will present the option to download full drug labels, indexing and risk evaluation and mitigation strategy (REMS) files, or mapping files that link an SPL’s set id to other relevant information and metadata. To view the full SPL release with labels, click on the first. The full releases will be at the bottom of this page in five parts.

    A more common way of leveraging the dataset is through DailyMed’s API client, RESTful. Querying via the RESTful API requires no account, key, or authentication, and returns data in either XML or JSON format. Related endpoints allow lookups by NDC code (/ndcs), drug name (/drugnames), RxNorm concept (/rxcuis), active ingredient (/uniis), and pharmacologic class (/drugclasses).

    The main way by which sections of an SPL are standardized is through Logical Observation Identifiers Names and Codes (LOINC®) code tagging. This allows for streamlined indexing into areas such as indications and usage, adverse reactions, dosage and administration, and other common sections.

    1. AMIA Informatics Summit. (2013 Mar 18.). . Retrieved June 25, 2026.

    • Malec SA, Boyce RD. AMIA Jt Summits Transl Sci Proc. 2020 May 30;2020:403-412. PMID: 32477661; PMCID: PMC7233092.

    Introduction

    The Unified Research data Sharing and Access (URSA) Initiative was launched in 2015 with the overall goal of making electronic health record (EHR) and other health data accessible and usable for research purposes across Rhode Island. This initiative is supported by Advance RI-CTR and coordinated by the Advance RI-CTR Biomedical Informatics, Bioinformatics, and Cyberinfrastructure Enhancement () Core with leadership and expertise provided by the Brown Center for Biomedical Informatics ().

    The Advance RI-CTR BIBCE Core collaborates with Brown University's Office of Information Technology and the Division of Research, including Research Integrity and Research Agreements & Contracting, and health data partners across Rhode Island to:

    • Coordinate processes for health data sharing and secure access within and across institutions;

    Standardized Healthcare Vocabularies

    References

    Resources

    Articles

    Links

    Extending the “Web of Drug Identity” with Knowledge Extracted from United States Product Labels
    Exploring Novel Computable Knowledge in Structured Drug Product Labels.
    DailyMed Full SPL Release download link
    DailyMed website

    Develop the requisite legal, ethical, and technical infrastructure between Brown and health data sharing partners;

  • Establish cross-institutional governance, including standard policies, procedures, and protocols for appropriate sharing and use of health data; and,

  • Provide documentation and training for health data requests, access, and use.

  • Through the URSA Initiative, the BIBCE Core provides expertise and infrastructure for conducting research using large-scale health datasets. The BIBCE Core is available to help researchers navigate the process of identifying options and solutions for storing, managing, and analyzing data from health data partners or other data sources.

    Complete Advance RI-CTR's Service Request Form to schedule a consultation with the BIBCE Core.

    BIBCE
    BCBI
    A stylized bear with the ursa major constellation. Unified Research data Sharing and Access Initiative in Rhode Island

    Visit other chapters in CODIAC for Health using the or menu in the upper left corner.

    Data Dictionary

    1. Main Provider File · npidata_pfile_*.csv

    One row per NPI. Repeating groups use a _N suffix; positions reflect the CSV column order (330 columns total).

    Position
    Field Name
    Description
    Code Set

    1

    NPI

    Non-primary practice locations for Type 1 & Type 2 NPIs. Join back to the main file on NPI.

    Position
    Field Name
    Description

    Additional 'other names' for Type 2 (organization) NPIs beyond the one stored in the main file.

    Position
    Field Name
    Description

    Health IT endpoints (Direct messaging, FHIR servers, HIE, etc.) associated with NPIs.

    Position
    Field Name
    Description

    Dataset Demographics

    SyntheticRI 1K

    Demographic
    Category
    Patient Count
    Percentage (%)

    Age

    < 18

    190

    16.9

    Demographic
    Category
    Patient Count
    Percentage (%)

    Youth Risk Behavior Surveillance System (YRBSS)

    Overview

    The Youth Risk Behavior Surveillance System (YRBSS) was established in 1990 by the U.S. Centers for Disease Control and Prevention (CDC) to monitor priority health risk behaviors and experiences that contribute to death, disability, and social problems among youth and young adults in the United States. The system monitors critical variables established during childhood and adolescence, including demographics, substance use, sexual behaviors, violence, as well as other student health behaviors and experiences. Data has been collected from over 5 million high school students through more than 2,300 separate surveys at national, state, territorial, tribal, and local levels. The YRBSS aims to determine the prevalence of health risk behaviors and assess trends over time. Published data, reports, questionnaires, and analysis tools are publicly accessible through the CDC YRBSS website. Data files are provided in Access and ASCII formats. All other data must be requested through the YRBSS Data Request Form.

    Methodology and Generation

    The YRBSS was created using a three-stage cluster sample design to produce a representative sample of 9th through 12th grade students in both public and private high schools. The selection process involved identifying schools systematically with probability proportional to enrollment, followed by systematic equal probability sampling of classes within a required subject or specific period. The survey has been distributed every two years. Once data was collected, responses underwent automated data edits to ensure range validity, logical consistency, and biologically reasonable values for height, weight, and body mass index (BMI). Records that were overly incomplete or with suspicious response patterns were excluded from the final dataset. A weighting factor was applied to each usable record to adjust for nonresponse and oversampling, rendering generalizable data that matches nationwide population projections.

    Standardized Healthcare Vocabularies

    Internal Question Codes (Questions 1-107)

    The core alphanumeric identifiers used to categorize each survey question and its corresponding clinical or behavioral concept.

    A standardized system of calculated variables where "1" represents a specific "Response of Interest" (ROI) and "2" represents all other valid responses.

    The specific reference data and sex-specific percentile limits used to define clinical classifications for BMI, Overweight, and Obesity.

    A nominal categorical classification system (values 1-8) that standardizes the reporting of American Indian/Alaskan Native, Asian, Black, Native Hawaiian/Pacific Islander, White, and Hispanic/Latino identities.

    Standardized response options used to identify and categorize sexual minority youth (ie. gay, lesbian, or bisexual).

    Standardized variables required for statistical software to account for the three-stage cluster sample design, ensuring that prevalence estimates accurately represent the national youth population.

    Standardized, shortened versions of response options (under 40 characters) used specifically as value labels in datasets and programs like SAS and SPSS to maintain technical clarity.

    1. U.S. Centers for Disease Control and Prevention. [Internet]. 2024. Site Index.

    2. U.S. Centers for Disease Control and Prevention. [Internet]. 2023 Sep.

    • Brener ND, Mpofu JJ, Krause KH, Everett Jones S, Thornton JE, Myles Z, et al. . MMWR Suppl. 2024 Oct 10;73(4):1–12. doi:10.15585/mmwr.su7304a1 PubMed PMID: 39378301; PubMed Central PMCID: PMC11559678.

    • Jorge V. Verlenden P, Ari Fodeman P, Natalie Wilkins P, Sherry Everett Jones P, Shamia Moore MPH, Kelly Cornett MS, et al. . MMWR Suppl. 2024;73. doi:10.15585/mmwr.su7304a9

    • Swedo EA, Niolon PH, Anderson KN, Li J, Brener N, Mpofu J, et al. . Pediatrics. 2024 Nov 1;154(5):e2024066633. doi:10.1542/peds.2024-066633 PubMed PMID: 39463258; PubMed Central PMCID: PMC11756604.

    3

    Provider Secondary Practice Location Address – Address Line 2

    Street address line 2 (suite, floor, etc.).

    4

    Provider Secondary Practice Location Address – City Name

    City of the secondary location.

    5

    Provider Secondary Practice Location Address – State Name

    State/territory code of the secondary location.

    6

    Provider Secondary Practice Location Address – Postal Code

    ZIP/postal code (may include ZIP+4).

    7

    Provider Secondary Practice Location Address – Country Code (If outside U.S.)

    ISO country code; populated only when outside the U.S.

    8

    Provider Secondary Practice Location Address – Telephone Number

    Phone number at the secondary location.

    9

    Provider Secondary Practice Location Address – Telephone Extension

    Phone extension at the secondary location.

    10

    Provider Practice Location Address – Fax Number

    Fax number at the secondary location.

    3

    Provider Other Organization Name Type Code

    Type of the alternate name (3 = DBA, 4 = Former Legal Business Name, 5 = Other Name).

    3

    Endpoint Type Description

    Full descriptive name of the endpoint type.

    4

    Endpoint

    The actual endpoint address (Direct email, FHIR/web-services URL, etc.).

    5

    Affiliation

    Whether the endpoint is affiliated with another organization (Y/N).

    6

    Endpoint Description

    Free-text description of the endpoint and its purpose.

    7

    Affiliation Legal Business Name

    Legal Business Name of the affiliated organization (when Affiliation = Y).

    8

    Use Code

    Short code for the endpoint's use (e.g., DIRECTMESSAGING).

    9

    Use Description

    Full description of the endpoint's use.

    10

    Other Use Description

    Free-text description when Use Code is 'Other'.

    11

    Content Type

    Short code for content exchanged (e.g., CCD).

    12

    Content Description

    Full description of the content type.

    13

    Other Content Description

    Free-text description when Content Type is 'Other'.

    14

    Affiliation Address Line One

    Street address line 1 of the affiliated organization.

    15

    Affiliation Address Line Two

    Street address line 2 of the affiliated organization.

    16

    Affiliation Address City

    City of the affiliated organization.

    17

    Affiliation Address State

    State of the affiliated organization.

    18

    Affiliation Address Country

    ISO country code of the affiliated organization.

    19

    Affiliation Address Postal Code

    Postal code of the affiliated organization.

    Unique 10-digit National Provider Identifier assigned by CMS. Primary key of the file.

    —

    2

    Entity Type Code

    1 = Individual, 2 = Organization. Blank only for deactivated records.

    Entity Type

    3

    Replacement NPI

    If this NPI was deactivated and replaced, the replacement NPI. Blank otherwise.

    —

    4

    Employer Identification Number (EIN)

    IRS EIN of the provider. SUPPRESSED in the public file for privacy.

    —

    5

    Provider Organization Name (Legal Business Name)

    Official legal business name of the organization. V.2 expanded this field's length.

    —

    6

    Provider Last Name (Legal Name)

    Legal last (family) name of the individual provider.

    —

    7

    Provider First Name

    Legal first (given) name. V.2 expanded this field's length.

    —

    8

    Provider Middle Name

    Middle name or initial of the individual provider.

    —

    9

    Provider Name Prefix Text

    Name prefix (e.g., Dr., Mr., Ms.).

    Name Prefix

    10

    Provider Name Suffix Text

    Name suffix (e.g., Jr., Sr., III).

    Name Suffix

    11

    Provider Credential Text

    Professional credential(s), e.g., MD, DO, NP, PA.

    —

    12

    Provider Other Organization Name

    Single alternate organization name (DBA, former name, etc.).

    —

    13

    Provider Other Organization Name Type Code

    Type of the alternate organization name (3, 4, 5).

    Other Name Type

    14

    Provider Other Last Name (Legal Name)

    Alternate last name of an individual provider.

    —

    15

    Provider Other First Name

    Alternate first name of an individual provider.

    —

    16

    Provider Other Middle Name

    Alternate middle name of an individual provider.

    —

    17

    Provider Other Name Prefix Text

    Name prefix for the alternate individual name.

    Name Prefix

    18

    Provider Other Name Suffix Text

    Name suffix for the alternate individual name.

    Name Suffix

    19

    Provider Other Credential Text

    Professional credential for the alternate individual name.

    —

    20

    Provider Other Last Name Type Code

    Type of the alternate individual name (1, 2, 5).

    Other Name Type

    21

    Provider First Line Business Mailing Address

    Street address line 1 of the mailing address.

    —

    22

    Provider Second Line Business Mailing Address

    Street address line 2 (suite, floor, PO box) of the mailing address.

    —

    23

    Provider Business Mailing Address City Name

    City of the mailing address.

    —

    24

    Provider Business Mailing Address State Name

    State/territory code of the mailing address.

    State Codes

    25

    Provider Business Mailing Address Postal Code

    ZIP/postal code (USPS 9-digit; may include ZIP+4).

    —

    26

    Provider Business Mailing Address Country Code (If outside U.S.)

    ISO country code; populated only when outside the U.S.

    Country Codes

    27

    Provider Business Mailing Address Telephone Number

    Phone number for the mailing address.

    —

    28

    Provider Business Mailing Address Fax Number

    Fax number for the mailing address.

    —

    29

    Provider First Line Business Practice Location Address

    Street address line 1 of the primary practice location.

    —

    30

    Provider Second Line Business Practice Location Address

    Street address line 2 of the primary practice location.

    —

    31

    Provider Business Practice Location Address City Name

    City of the primary practice location.

    —

    32

    Provider Business Practice Location Address State Name

    State/territory code of the primary practice location.

    State Codes

    33

    Provider Business Practice Location Address Postal Code

    ZIP/postal code of the primary practice location.

    —

    34

    Provider Business Practice Location Address Country Code (If outside U.S.)

    ISO country code; populated only when outside the U.S.

    Country Codes

    35

    Provider Business Practice Location Address Telephone Number

    Phone number at the primary practice location.

    —

    36

    Provider Business Practice Location Address Fax Number

    Fax number at the primary practice location.

    —

    37

    Provider Enumeration Date

    Date the NPI was first assigned (MM/DD/YYYY).

    —

    38

    Last Update Date

    Most recent date any field on the record changed (MM/DD/YYYY).

    —

    39

    NPI Deactivation Reason Code

    Reason the NPI was deactivated, if applicable.

    Deactivation Reason

    40

    NPI Deactivation Date

    Date the NPI was deactivated. Blank for active providers.

    —

    41

    NPI Reactivation Date

    Date the NPI was reactivated after a prior deactivation.

    —

    42

    Provider Sex Code

    Sex of an individual provider (formerly 'Provider Gender Code'). Not used for organizations.

    Sex

    43

    Authorized Official Last Name

    Last name of the official authorized to act for the organization.

    —

    44

    Authorized Official First Name

    First name of the authorized official.

    —

    45

    Authorized Official Middle Name

    Middle name or initial of the authorized official.

    —

    46

    Authorized Official Title or Position

    Job title/position of the authorized official (e.g., CEO, CFO).

    —

    47

    Authorized Official Telephone Number

    Phone number of the authorized official.

    —

    48–107

    Healthcare Provider Taxonomy Code_N

    NUCC taxonomy code classifying provider type/specialization (e.g., 207Q00000X). Interleaved per occurrence with the three fields below.

    Taxonomy (NUCC)

    48–107

    Provider License Number_N

    State-issued license number for the taxonomy at the same position.

    —

    48–107

    Provider License Number State Code_N

    State that issued the license at the same position.

    State Codes

    48–107

    Healthcare Provider Primary Taxonomy Switch_N

    Y if this is the provider's primary taxonomy (only one Y per NPI).

    Primary Taxonomy Switch

    108–307

    Other Provider Identifier_N

    Legacy/plan-specific identifier (e.g., Medicaid ID). Masked: SSN=$$$$$$$$$, ITIN=*********, EIN=========.

    —

    108–307

    Other Provider Identifier Type Code_N

    Type/issuer system of the identifier at the same position.

    Other Provider ID Type

    108–307

    Other Provider Identifier State_N

    State code for the identifier (used when issued by a state Medicaid plan).

    State Codes

    108–307

    Other Provider Identifier Issuer_N

    Name of the plan/organization that issued the identifier.

    —

    308

    Is Sole Proprietor

    Whether the individual operates as a sole proprietor (Y/N/X).

    Sole Proprietor

    309

    Is Organization Subpart

    Whether the organization is a subpart of a larger parent (Y/N/X).

    Subpart

    310

    Parent Organization LBN

    Legal Business Name of the parent organization. SUPPRESSED in the public file.

    —

    311

    Parent Organization TIN

    Tax ID of the parent organization. SUPPRESSED in the public file.

    —

    312

    Authorized Official Name Prefix Text

    Name prefix of the authorized official.

    Name Prefix

    313

    Authorized Official Name Suffix Text

    Name suffix of the authorized official.

    Name Suffix

    314

    Authorized Official Credential Text

    Professional credential of the authorized official.

    —

    315–329

    Healthcare Provider Taxonomy Group_N

    Grouping code for the taxonomy at the same position (e.g., 193200000X).

    Group Taxonomy

    330

    Certification Date

    Date the provider certified the application information is accurate.

    —

    1

    NPI

    NPI of the provider for this secondary location. Join key to the main file.

    2

    Provider Secondary Practice Location Address – Address Line 1

    Street address line 1 of the secondary location.

    1

    NPI

    NPI of the organizational provider this name belongs to. Join key to the main file.

    2

    Provider Other Organization Name

    The alternate organization name (DBA, former name, etc.).

    1

    NPI

    NPI of the provider this endpoint belongs to. Join key to the main file.

    2

    Endpoint Type

    Short code/label for the endpoint type (e.g., DIRECT, FHIR).

    2. Practice Location Reference File · pl_pfile_*.csv

    3. Other Names Reference File · othername_pfile_*.csv

    4. Endpoint Reference File · endpoint_pfile_*.csv

    Binary Variables (Question N# & word)

    2000 CDC Growth Charts

    Standard Race/Ethnicity Labels (raceeth)

    Sexual Identity and Sexual Contact Labels

    Complex Sampling Identifiers (Weight, Stratum, PSU)

    Short Response Labels

    References

    Resources

    Articles

    Links

    Youth Risk Behavior Surveillance System (YRBSS)
    2023 YRBS Data Users Guide
    Overview and Methods for the Youth Risk Behavior Surveillance System — United States, 2023
    Mental Health and Suicide Risk Among High School Students and Protective Factors — Youth Risk Behavior Survey, United States, 2023
    Prevalence of Adverse Childhood Experiences Among Adolescents
    CDC YRBSS Data & Documentation
    CDC YRBSS Questionnaires
    CDC YRBSS Data Request Form
    Table of Contents

    90598

    26.0

    40-59

    89353

    25.7

    60+

    106257

    30.5

    Gender

    F

    174621

    50.2

    M

    173499

    49.8

    Race

    Asian

    12244

    3.5

    Black

    27311

    7.8

    Hawaiian

    4672

    1.3

    Native

    3404

    1.0

    Other

    4602

    1.3

    White

    295887

    85.0

    Ethnicity

    Hispanic

    49410

    14.2

    Nonhispanic

    298710

    85.8

    18-39

    318

    28.3

    40-59

    277

    24.6

    60+

    339

    30.2

    Gender

    F

    581

    51.7

    M

    543

    48.3

    Race

    Asian

    33

    2.9

    Black

    88

    7.8

    Hawaiian

    19

    1.7

    Native

    12

    1.1

    Other

    11

    1.0

    White

    961

    85.5

    Ethnicity

    Hispanic

    159

    14.1

    Nonhispanic

    965

    85.9

    Age

    < 18

    61912

    17.8

    SyntheticRI 300K

    18-39

    Pediatric Psychiatry Emergency Services (PediPES) at Hasbro Children’s

    Overview

    The Pediatric Psychiatry Emergency Services (PediPES) dataset consists of electronic health record (EHR) data for patients younger than 18 years old evaluated in the emergency department at Hasbro Children's Emergency Department in Providence, Rhode Island for psychiatric concerns. The dataset includes visit-level demographic, socioeconomic, geographic, and clinical variables, providing a comprehensive view of the pediatric mental health population served by the hospital. The dataset also captures a diverse range of mental health presentations, including suicidal ideation, suicide attempts, self-injurious behaviors, mood disorders, anxiety disorders, psychotic disorders, and behavioral concerns. This dataset is part of LEAPPES (Leveraging EHRs and AI for Pediatric Psychiatry Emergency Services), a multi-institutional and multi-disciplinary collaboration and offers valuable insight into the mental health needs, care patterns, and outcomes of those under the age of 18 presenting for emergency psychiatric evaluation.

    Methodology and Generation

    The dataset was generated from electronic health record (EHR) data collected during routine clinical care. Variables were derived from both structured and unstructured data sources. Structured variables were obtained from standardized drop-down menus and other discrete fields within the EHR, while additional clinical information was extracted from free-text documentation using basic natural language processing (NLP) techniques. This approach enabled the inclusion of demographic, socioeconomic, geographic, and clinical variables that may not have been consistently captured in structured fields alone.

    Terminology

    Diagnoses

    • Mental health and medical diagnoses are documented using the International Classification of Diseases, Clinical Modification (ICD-10-CM)

    • Final (Billing) Diagnoses ICD-10 Codes - F Codes: Mental, Behavioral, and Neurodevelopmental Disorders; These are psychiatric and behavioral health diagnoses, which are particularly relevant in a pediatric psychiatric emergency setting.

    • Final (Billing) Diagnoses ICD-10 Codes - Z Codes: Factors Influencing Health Status and Contact with Health Services; These codes describe social circumstances, healthcare encounters, or reasons for seeking care rather than diseases.

    • Final (Billing) Diagnoses ICD-10 Codes - Other Codes: All non-F and non-Z ICD-10 codes, representing medical conditions, injuries, poisonings, symptoms, and other health problems.

    • Suicide risk is assessed using the Columbia-Suicide Severity Rating Scale (C-SSRS): standardized tool that evaluates an individual's risk of suicide by assessing the severity and type of suicidal thoughts and behaviors.

    • Boarding: A patient remains in the emergency department or another temporary hospital location after being evaluated and determined to need a higher level of psychiatric care, but appropriate placement is not immediately available.

    • Inpatient: The patient is admitted to a psychiatric hospital or psychiatric unit for 24-hour supervision, stabilization, and intensive treatment.

    • Outpatient: The patient is discharged from the emergency psychiatric service and receives treatment while continuing to live at home.

    • Brown KA, Donise KR, Cancilliere MK, Aluthge DP, Chen ES. . AMIA Annu Symp Proc. 2024 Jan 11;2023:864-873. PMID: 38222397; PMCID: PMC10785882.

    • Kim W, Donise KR, Brown KA, Cancilliere MK, Chen ES. AMIA Jt Summits Transl Sci Proc. 2024 May 31;2024:565-574. PMID: 38827092; PMCID: PMC11141824.

    Partial programs: A structured, intensive treatment program that provides several hours of psychiatric care and therapy during the day while allowing the patient to return home each evening. Partial programs serve as an intermediate level of care between inpatient hospitalization and traditional outpatient treatment.

    Suicide Risk Assessment

    PediPES Disposition

    Resources

    Articles

    Characterizing Autism Spectrum Disorder and Predicting Suicide Risk for Pediatric Psychiatric Emergency Services Encounters
    Identifying and Characterizing the Transgender and Nonbinary Population Presenting to Pediatric Psychiatry Emergency Services.

    All of Us

    Overview

    The All of Us dataset is a large, longitudinal U.S. health research resource that integrates clinical, behavioral, genomic, and wearable-device data from a diverse participant population.

    Data Types

    The dataset includes six major data types collected from participants:

    1. Electronic Health Records (EHRs): Clinical records from participating healthcare organizations (OMOP Common Data Model). It includes diagnoses, medications, procedures, laboratory results, and clinical visits. (393k+ participants)

    2. Participant Surveys: Self-reported data covering demographics, lifestyle, social determinants of health, family and personal health history, health care access and utilization, behavioral health and emotional health history (633k+ participants).

    3. Physical Measurements: Standardized measurements that include height, weight, waist and hip circumference, blood pressure, and heart rate. Collectively from EHR data as well as self-reported through surveys (509k+ participants).

    4. Biosamples: Blood and urine samples from 568,000+ participants, supporting genomic and other laboratory analyses.

    5. Genomics: Whole genome sequences and genotyping arrays from 447,000+ participants, available in the Controlled Tier.

    6. Wearable Devices (Digital Health): Biometric data from Fitbit devices including heart rate, physical activity, sleep patterns, device data. (59k+ participants)

    Data are organized into three access tiers based on sensitivity and researcher eligibility:

    1. Public Tier: Aggregate, de-identified data available to everyone via the Data Browser and Data Snapshots. Doesn’t require registration.

    2. Registered Tier: De-identified individual-level data including EHRs, wearables, surveys, and physical measurements. Accessible only to approved researchers on the Researcher Workbench.

    3. Controlled Tier: Contains individual-level genomic data (whole genome sequences and genotyping arrays). Requires additional access approval beyond the Registered Tier.

    Data flow through several stages before reaching researchers. Participants contribute data directly via participant portals and biosample donation. Healthcare Provider Organization (HPO) staff submit local EHR data through the HealthPro application. Genomics partners (genetic counseling resources, clinical validation laboratories, and genome centers) process biosamples for sequencing and genotyping. All raw data enters a central Raw Data Repository, then passes through a curation pipeline before being organized into the Curated Data Repository, from which the Public, Registered, and Controlled tiers are made available to researchers through the All of Us Research Hub.

    Electronic health records are standardized using the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), maintained by the international Observational Health Data Sciences and Informatics (OHDSI) collaborative. The OMOP CDM organizes data around a central Person table linked to standardized tables including Visit Occurrence, Procedure Occurrence, Drug Exposure, Condition Occurrence, Measurement, and Observation. Survey questionnaires and physical measurements are mapped into the Observation and Measurement tables respectively, creating a unified structure across all data sources.

    The dataset uses the OMOP CDM and its associated standardized vocabularies.

    • SNOMED CT

    • LOINC

    • RxNorm

    • ICD-10-CM / ICD-9-CM

    Access to Registered and Controlled Tier data requires agreement to the Data User Code of Conduct (DUCC), which includes the following key requirements:

    • Participants may never be identified or re-identified.

    • Data may be used for biomedical or health research purposes only.

    • All of Us data cannot be linked with external datasets at the individual participant level.

    1. All of Us Research Program Investigators; Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, Jenkins G, Dishman E. (2019). . N Engl J Med. 2019 Aug 15;381(7):668-676. doi: 10.1056/NEJMsr1809937. PMID: 31412182; PMCID: PMC8291101.

    2. Mayo KR, Basford MA, Carroll RJ, Dillon M, Fullen H, Leung J, et al. . Annu Rev Biomed Data Sci. 2023 Aug 10;6:443-464. doi: 10.1146/annurev-biodatasci-122120-104825. PMID: 37561600.

    3. Ginsburg GS, Denny JC, Schully SD. Sci Transl Med. 2023 Dec 13;15(726):eade9214. doi: 10.1126/scitranslmed.ade9214. Epub 2023 Dec 13. PMID: 38091411; PMCID: PMC12374748.

    CPT-4 / HCPCS

  • NDC (National Drug Code)

  • CVX

  • PPI (Participant Provided Information): Custom All of Us vocabulary for survey responses not mappable to existing standards.

  • Participant-level data cannot be shared, redistributed, or published.
  • Published statistics must reflect a minimum of 20 participants per cell (aka the ’minimum count rule’). Public Tier applies this same rounding convention.

  • The program must be notified at least two weeks before any publication or presentation using the data.

  • Final manuscripts must be submitted to PubMed Central immediately upon publication with no embargo period.

  • Each Workspace must include an accurate and meaningful description of the research, which becomes publicly viewable in the Research Projects Directory.

  • National Institutes of Health. (n.d.). .

  • All of Us Research Hub. (n.d.). . .

  • All of Us Research Hub. (n.d.). .

  • Data Access Tiers

    Methodology and Generation

    Data Ecosystem and Pipeline

    Standardization with OMOP

    Standardized Healthcare Vocabularies

    Data Use Compliance Requirements

    References

    Resources

    Links

    The "All of Us" Research Program
    The All of Us Data and Research Center: Creating a Secure, Scalable, and Sustainable Ecosystem for Biomedical Research
    Data-driven science and diversity in the All of Us Research Program.
    All of Us Research Hub
    All of Us Data Browser (Public)
    All of Us Researcher Workbench
    All of Us Research Program
    Data Snapshots
    Data Methods
    Researcher Workbench User Support Hub
    All of Us Research Projects Directory
    All of Us Publications
    Athena – OMOP Vocabulary Browser
    OHDSI / OMOP Common Data Model

    Surveillance, Epidemiology, and End Results (SEER)

    Overview

    The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. SEER collects cancer incidence data from population-based cancer registries covering approximately 47.9 percent of the U.S. population. The SEER datasets include data on patient demographics, primary tumor site, tumor morphology, stage at diagnosis, and first course of treatment. [1]

    SEER offers the following datasets:

    • SEER Research Data

      • Register with any valid email

      • Excludes geography, month and year of diagnosis, and other demographic fields

    • SEER Research Plus and NCCR Data

      • Requires user authentication through eRA Commons or an HHS account.

      • Includes geography, month, and year of diagnosis, other demographic fields

    Visit for a deeper comparison of the datasets. Learn more about SEER and SEER Datasets on the .

    1. National Cancer Institute. (n.d.).. Retrieved May 1, 2024.

    Includes excluding geography

    References

    Resources

    Links

    SEER
    SEER website
    SEER Data
    SEER Website
    SEER Data Products
    SEER Data Access Request Process
    National Childhood Cancer Registry (NCCR) data

    Data Counts

    Table headers are shown in this format Variable (Code)

    1. age (AGE)

    Value
    Count
    Percent

    <missing>

    4852521

    67.5707

    22

    Value
    Count
    Percent
    Value
    Count
    Percent
    Value
    Count
    Percent
    Value
    Count
    Percent
    Value
    Count
    Percent
    Value
    Count
    Percent
    Value
    Count
    Percent
    Value
    Count
    Percent
    Value
    Count
    Percent
    Value
    Count
    Percent

    2

    47961

    0.6679

    7

    7762

    0.1081

    120101

    3576

    0.0498

    530101

    3561

    0.0496

    370101

    2794

    0.0389

    260101

    2453

    0.0342

    130101

    2382

    0.0332

    180101

    2212

    0.0308

    1

    59763

    0.8322

    4

    7735

    0.1077

    2

    4067

    0.0566

    7

    564

    0.0079

    9

    259

    0.0036

    4

    1122412

    15.6294

    5

    1097142

    15.2776

    3

    205142

    2.8566

    2

    104731

    1.4584

    9

    16874

    0.235

    1

    6201

    0.0863

    8

    31

    0.0004

    9999999999999 9 29 9 9 99999999 99 9

    5

    0.0001

    1

    762633

    10.6196

    0

    297044

    4.1363

    9

    6187

    0.0862

    7

    5021

    0.0699

    4

    4027

    0.0561

    3

    1991

    0.0277

    5

    1619

    0.0225

    21111111112

    633

    0.0088

    3

    1411888

    19.6604

    1

    784373

    10.9223

    4

    605305

    8.4288

    5

    231289

    3.2207

    7

    9002

    0.1254

    9

    6852

    0.0954

    38888 11 522 2132

    700

    0.0097

    28888 11 522 2132

    421

    0.0059

    2

    88835

    1.237

    7

    2106

    0.0293

    9

    1509

    0.021

    1

    168134

    2.3412

    4

    7346

    0.1023

    2

    3373

    0.047

    7

    749

    0.0104

    9

    194

    0.0027

    7

    298705

    4.1594

    6

    276241

    3.8466

    5

    215407

    2.9995

    21

    202120

    2.8145

    4

    178366

    2.4837

    99

    168227

    2.3425

    77

    145925

    2.032

    3

    143969

    2.0048

    2

    425445

    5.9243

    3

    234429

    3.2644

    4

    215531

    3.0012

    7

    43925

    0.6117

    8

    30124

    0.4195

    9

    4888

    0.0681

    1

    1818420

    25.3213

    7

    19030

    0.265

    9

    6436

    0.0896

    9 99999999999999999999 9099999999999999999999 9 29 9 9 99999999

    4

    0.0001

    1107 1 2021012032032031011 3115312188841072502006010172 1 0114210

    2

    0

    2 10120355520220120422 41912588856771351355040171322 11111122031422

    2

    0

    2 1021012032023011021 3243712111841051371255040192 22 11112122551422

    2

    0

    9 99999999999999999999 90999999999999999999990799 1 999999

    2

    0

    264883

    3.6885

    12

    104228

    1.4514

    72

    78653

    1.0952

    60

    43002

    0.5988

    62

    41778

    0.5818

    65

    40228

    0.5602

    55

    39915

    0.5558

    50

    39649

    0.5521

    58

    39535

    0.5505

    <missing>

    5830436

    81.1881

    1

    376807

    5.247

    <missing>

    6705707

    93.3761

    3

    403299

    5.6159

    <missing>

    2787825

    38.8201

    6

    1532501

    21.3399

    <missing>

    4388211

    61.1053

    2

    1098353

    15.2944

    <missing>

    1585951

    22.0842

    2

    1468394

    20.4472

    <missing>

    6303754

    87.779

    1

    785190

    10.9337

    <missing>

    6748789

    93.976

    3

    252809

    3.5203

    <missing>

    4275582

    59.5369

    8

    530471

    7.3867

    <missing>

    3230757

    44.9879

    1

    2996295

    41.723

    <missing>

    2554029

    35.5645

    2

    2411430

    33.5789

    2. cholesterol checked (BLOODCHO)

    3. diagnosed diabetes (DIABETE3)

    4. education level (EDUCA)

    5. gender (SEX)

    6. general health (GENHLTH)

    7. health insurance coverage (HLTHPLN1)

    8. high blood pressure (BPHIGH4)

    9. income level (INCOME2)

    10. routine checkup (CHECKUP1)

    11. smoked 100 cigarettes (SMOKE100)

    Dataset Demographics

    MIMIC-IV (All Patients)
    Value

    Unique Patient Count

    364,627

    Gender

    364,627

    MIMIC-IV (hosp module v3.1)
    Value
    MIMIC-IV (icu module v2.2)
    Value
    MIMIC-IV (ed module v2.2)
    Value

    Female

    191,984

    Male

    172,643

    Anchor Age Distribution (nonnormal)

    48(29-65)

    Living Status

    Alive

    326,326

    Dead

    38301

    Full hospital admission count

    546,028

    Unique Patient Count

    223,452

    Unique Gender Counts

    Stays Count

    94,458

    Unique patients count

    65,366

    Unique Gender Counts

    Full ED visit count

    425,087

    Unique Patient count

    205,504

    Led to hospital admissions

    203,016

    Female

    117,736

    Male

    105,716

    Age at admission distribution (non-normal)

    61(45-74)

    Living Status

    Alive

    186,570

    Dead

    36,882

    Condensed Race/Ethnicity

    White

    147,029

    Black

    28,972

    Unknown/Other

    23,448

    Hispanic/Latino/Portuguese

    13,234

    Asian American and Pacific Islander

    10,496

    Multiple race/ethnicity

    273

    Unique Insurance Type Counts

    Medicare

    88674

    Private

    83068

    Medicaid

    38257

    Other

    7003

    No charge

    147

    Expanded Race/Ethnicity distribution counts

    WHITE

    137,946

    BLACK/AFRICAN AMERICAN

    23,404

    UNKNOWN

    9552

    OTHER

    9391

    WHITE - OTHER EUROPEAN

    6548

    ASIAN

    4182

    HISPANIC/LATINO - PUERTO RICAN

    3863

    ASIAN - CHINESE

    3526

    HISPANIC OR LATINO

    2618

    HISPANIC/LATINO - DOMINICAN

    2520

    UNABLE TO OBTAIN

    2468

    BLACK/CAPE VERDEAN

    2357

    WHITE - RUSSIAN

    2299

    BLACK/CARIBBEAN ISLAND

    1580

    BLACK/AFRICAN

    1522

    PATIENT DECLINED TO ANSWER

    998

    ASIAN - SOUTH EAST ASIAN

    869

    ASIAN - ASIAN INDIAN

    826

    WHITE - EASTERN EUROPEAN

    813

    HISPANIC/LATINO - GUATEMALAN

    780

    WHITE - BRAZILIAN

    739

    PORTUGUESE

    738

    HISPANIC/LATINO - SALVADORAN

    579

    AMERICAN INDIAN/ALASKA NATIVE

    481

    HISPANIC/LATINO - MEXICAN

    470

    HISPANIC/LATINO - COLUMBIAN

    433

    SOUTH AMERICAN

    369

    ASIAN - KOREAN

    349

    HISPANIC/LATINO - HONDURAN

    288

    NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER

    257

    HISPANIC/LATINO - CUBAN

    240

    HISPANIC/LATINO - CENTRAL AMERICAN

    227

    MULTIPLE RACE/ETHNICITY

    220

    Unique Language Counts

    English

    202713

    Spanish

    6783

    Chinese

    3369

    Russian

    2415

    Kabuverdianu

    1750

    Portuguese

    1452

    Haitian

    1003

    Other

    608

    Vietnamese

    494

    Arabic

    303

    Italian

    302

    Modern Greek (1453-)

    277

    Persian

    166

    Korean

    160

    American Sign Language

    152

    Thai

    124

    Polish

    123

    Amharic

    104

    Khmer

    103

    Hindi

    95

    Japanese

    92

    French

    82

    Bengali

    67

    Armenian

    45

    Somali

    36

    Female

    28,646

    Male

    36,720

    Age at ICU admission distribution (nonnormal)

    66(55-77)

    Length of stay distribution (normal)

    1.97(1.09-3.86)

    First Care Unit

    Medical Intensive Care Unit (MICU)

    20703

    Medical/Surgical Intensive Care Unit (MICU/SICU)

    15449

    Cardiac Vascular Intensive Care Unit (CVICU)

    14771

    Surgical Intensive Care Unit (SICU)

    13009

    Coronary Care Unit (CCU)

    10775

    Trauma SICU (TSICU)

    10474

    Neuro Intermediate

    5776

    Neuro Surgical Intensive Care Unit (Neuro SICU)

    1751

    Neuro Stepdown

    1421

    Surgery/Vascular/Intermediate

    145

    PACU

    122

    Intensive Care Unit (ICU)

    33

    Medicine

    16

    Surgery/Trauma

    10

    Medicine/Cardiology Intermediate

    1

    Med/Surg

    1

    Neurology

    1

    Unique Gender Counts

    205,504

    Female

    109,533

    Male

    95,971

    Age at ED visit distribution (normal)

    54(35-69)

    Arrival Transport

    WALK IN

    251849

    AMBULANCE

    155752

    UNKNOWN

    15352

    OTHER

    1266

    HELICOPTER

    868

    Disposition

    HOME

    241632

    ADMITTED

    158010

    TRANSFER

    7025

    LEFT WITHOUT BEING SEEN

    6,155

    ELOPED

    5,710

    OTHER

    4,297

    LEFT AGAINST MEDICAL ADVICE

    1,881

    EXPIRED

    377

    Data Statistics

    1. Dataset Shape

    Rows
    Columns

    222,642

    551

    2. Files & Years

    year
    rows
    column
    count
    mean
    std
    min
    25%
    50%
    75%
    max
    value
    count
    value
    count
    value
    count
    value
    count
    value
    count
    value
    count
    value
    count
    value
    count
    value
    count

    2001

    13601

    2003

    15214

    2005

    13917

    2007

    14041

    2011

    15425

    2013

    13583

    2017

    14765

    2019

    13677

    2021

    17232

    2023

    20103

    col_222_222

    219616

    98.64

    col_216_216

    219558

    98.61

    col_213_213

    219316

    98.51

    col_364_364

    219198

    98.45

    col_365_365

    219153

    98.43

    col_239_239

    219153

    98.43

    QNSHPARG

    219105

    98.41

    col_238_238

    218733

    98.24

    QNOTHH

    218188

    98

    col_271_271

    217150

    97.53

    col_126_126

    213511

    95.9

    RACEORIG

    212726

    95.55

    QNIUDIMP

    212548

    95.47

    col_282_282

    212059

    95.25

    col_136_136

    212059

    95.25

    col_129_129

    211854

    95.15

    col_138_138

    211847

    95.15

    col_284_284

    211847

    95.15

    col_135_135

    211792

    95.13

    col_281_281

    211792

    95.13

    QNSPDRK3

    211754

    95.11

    col_385_385

    211717

    95.09

    col_283_283

    211696

    95.08

    2007.030569

    10.384386

    1991

    1997

    2005

    2017

    2023

    Q1

    201865

    5.103777

    1.243429

    1

    4

    5

    6

    7

    Q7

    210300

    32.700481

    35.218022

    1

    1

    4

    63.5

    180.99

    Q38

    211784

    1.504944

    1.234843

    1

    1

    1

    1

    7

    Q45

    203077

    2.045323

    1.858696

    1

    1

    1

    2

    8

    PSU

    220993

    227508.118

    222704.8756

    1

    37153

    160050

    371830

    921211

    7

    30584

    3

    21452

    NaN

    20776

    1

    371

    2

    287

    2

    45740

    NaN

    38121

    5

    277

    3

    28507

    6

    26343

    4

    14054

    7

    2385

    8

    1647

    5

    986

    NaN

    12426

    3

    12027

    2

    9784

    5

    9319

    1

    7803

    1.68

    5566

    B

    4964

    4

    7989

    5

    7904

    1.68

    7686

    1.63

    7486

    1.7

    7481

    1.73

    7044

    1.6

    6954

    NaN

    9219

    54.43

    4428

    58.97

    4389

    63.5

    3965

    68.04

    3872

    61.24

    3613

    56.7

    3482

    5

    20049

    4

    11023

    3

    10223

    6

    5848

    NaN

    40759

    4

    26813

    3

    18591

    6

    833

    1991

    12272

    1993

    16296

    1995

    10904

    1997

    16263

    1999

    column

    missing_count

    missing_percent

    SITE

    222642

    100

    col_211_211

    222119

    year

    5

    51555

    6

    51323

    4

    46293

    1

    93503

    2

    91077

    NaN

    38062

    4

    46371

    3

    46302

    1

    45831

    2

    67966

    1

    41242

    NaN

    39512

    E

    58300

    C

    19353

    4

    15900

    1

    24558

    NaN

    22291

    2

    8056

    1

    65002

    2

    23944

    3

    13398

    1

    69609

    2

    58867

    NaN

    47023

    1

    47229

    5

    45914

    2

    42503

    3. Missing Values

    4. Numeric Variables

    5. Categorical Variables

    Q1

    Q2

    Q3

    Q4

    Q5

    Q6

    Q7

    Q8

    Q9

    15349

    99.77

    222642

    Data Statistics

    1. Dataset Shape

    Rows
    Columns

    7181394

    20

    2. Records by Year

    Year
    Records
    Statistic
    Value
    Column
    Count
    Mean
    75%
    Max
    Value
    Count
    Value
    Count
    Value
    Count
    Value
    Count
    Value
    Count
    Value
    Count
    Value
    Count
    Value
    Count
    Value
    Count
    Value
    Count
    Value
    Count

    Condition Prevalences

    The table below lists the most frequently occurring ICD-10-CM diagnosis codes recorded in the diagnoses_icd table of the MIMIC-IV Hosp module, ranked by number of unique patients.

    ICD-10
    Description
    Total Count
    Unique Patients

    1990

    81557

    1991

    87846

    1992

    96213

    1993

    102263

    1994

    Count

    1585906

    Mean

    1464.934

    Std

    778.4

    Column

    Missing Count

    Missing Percent

    BPHIGH4

    6748789

    93.98

    BPHIGH

    6723517

    YEAR

    7181394

    2010.506928

    2020

    2024

    NaN

    4852521

    22

    264883

    12

    104228

    NaN

    4388211

    2

    1098353

    1

    762633

    NaN

    1585951

    2

    1468394

    3

    1411888

    NaN

    6748789

    3

    252809

    1

    168134

    NaN

    6723517

    120101

    3576

    530101

    3561

    NaN

    5830436

    1

    376807

    2

    47961

    NaN

    2554029

    2

    2411430

    1

    1818420

    NaN

    6705707

    3

    403299

    1

    59763

    NaN

    2787825

    6

    1532501

    4

    1122412

    NaN

    4275582

    8

    530471

    7

    298705

    NaN

    5886236

    1

    287603

    2

    43660

    3. Record Lengths

    4. Missing Variables

    5. Numeric Variables

    6. Categorical Variables

    AGE

    SEX

    GENHLTH

    BPHIGH4

    BP HIGH

    BLOODCHO

    SMOKE100

    DIABETE3

    EDUCA

    INCOME2

    CHOLCHK

    I10

    Essential (primary) hypertension

    190,198

    105853

    1995

    113934

    1996

    124085

    1997

    135582

    1998

    149342

    1999

    159989

    2000

    184450

    2001

    212510

    2002

    247964

    2007

    430912

    2008

    414509

    2009

    432607

    2010

    451075

    2011

    506467

    2012

    475687

    2013

    491773

    2020

    401958

    2021

    438693

    2022

    445132

    2023

    433323

    2024

    457670

    Min

    450

    25%

    550

    50%

    1696

    75%

    2366

    Max

    2366

    93.62

    DIABETE3

    6705707

    93.38

    DIABETES

    6447493

    89.78

    HLTHPLN1

    6303754

    87.78

    CHECKUP

    6229092

    86.74

    CHOLCHK

    5886236

    81.97

    BLOODCHO

    5830436

    81.19

    RAW_RECORD

    5595488

    77.92

    RAW_RECORD_LENGTH

    5595488

    77.92

    AGE

    4852521

    67.57

    SEX

    4388211

    61.11

    INCOME2

    4275582

    59.54

    CHECKUP1

    3230757

    44.99

    EDUCA

    2787825

    38.82

    72

    78653

    60

    43002

    0

    297044

    9

    6187

    1

    784373

    4

    605305

    4

    7346

    2

    3373

    370101

    2794

    260101

    2453

    7

    7762

    120101

    3576

    7

    19030

    9

    6436

    4

    7735

    2

    4067

    5

    1097142

    3

    205142

    6

    276241

    5

    215407

    3

    27354

    4

    14108

    91,186

    E785

    Hyperlipidemia, unspecified

    151,863

    71,607

    K219

    Gastro-esophageal reflux disease without esophagitis

    104,785

    49,543

    Z87891

    Personal history of nicotine dependence

    94,511

    46,243

    F329

    Major depressive disorder, single episode, unspecified

    80,240

    40,186

    N179

    Acute kidney failure, unspecified

    65,020

    38,389

    I2510

    Atherosclerotic heart disease of native coronary artery without angina pectoris

    89,794

    37,934

    F419

    Anxiety disorder, unspecified

    61,310

    35,075

    E119

    Type 2 diabetes mellitus without complications

    69,343

    32,249

    D649

    Anemia, unspecified

    45,532

    31,640

    I4891

    Unspecified atrial fibrillation

    58,092

    28,276

    Z7901

    Long term (current) use of anticoagulants

    53,592

    25,499

    N390

    Urinary tract infection, site not specified

    37,083

    25,402

    D62

    Acute posthemorrhagic anemia

    29,544

    24,328

    E039

    Hypothyroidism, unspecified

    56,521

    24,305

    Z20822

    Contact with and (suspected) exposure to COVID-19

    33,113

    23,629

    E669

    Obesity, unspecified

    36,221

    22,020

    Z66

    Do not resuscitate

    29,429

    21,712

    NoDx

    37,659

    21,685

    E871

    Hypo-osmolality and hyponatremia

    29,893

    20,624

    E872

    Acidosis

    25,530

    19,921

    Y929

    Unspecified place or not applicable

    24,287

    19,660

    I129

    Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease

    41,811

    19,507

    G4733

    Obstructive sleep apnea (adult) (pediatric)

    41,489

    18,829

    Z794

    Long term (current) use of insulin

    47,242

    18,102

    I509

    Heart failure, unspecified

    40,557

    17,746

    N189

    Chronic kidney disease, unspecified

    33,252

    17,333

    J449

    Chronic obstructive pulmonary disease, unspecified

    36,287

    17,278

    F17200

    Nicotine dependence, unspecified, uncomplicated

    29,027

    17,260

    K5900

    Constipation, unspecified

    22,403

    16,685

    J189

    Pneumonia, unspecified organism

    20,588

    16,409

    E860

    Dehydration

    19,470

    15,574

    D696

    Thrombocytopenia, unspecified

    20,148

    14,902

    E780

    Pure hypercholesterolemia

    22,301

    14,817

    Z7902

    Long term (current) use of antithrombotics/antiplatelets

    22,059

    14,266

    G8929

    Other chronic pain

    26,416

    14,241

    F17210

    Nicotine dependence, cigarettes, uncomplicated

    24,106

    14,207

    I252

    Old myocardial infarction

    30,455

    14,033

    Z370

    Single live birth

    19,540

    13,882

    D72829

    Elevated white blood cell count, unspecified

    16,100

    13,638

    Z23

    Encounter for immunization

    14,437

    13,392

    Z7982

    Long term (current) use of aspirin

    18,257

    13,285

    Z8673

    Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits

    25,723

    13,211

    E876

    Hypokalemia

    16,738

    12,969

    R079

    Chest pain, unspecified

    16,132

    12,917

    F1010

    Alcohol abuse, uncomplicated

    20,250

    12,780

    R001

    Bradycardia, unspecified

    15,518

    12,719

    I959

    Hypotension, unspecified

    14,314

    12,467

    Y838

    Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

    14,567

    12,425

    A419

    Sepsis, unspecified organism

    15,496

    12,000

    E875

    Hyperkalemia

    17,214

    11,896

    N400

    Benign prostatic hyperplasia without lower urinary tract symptoms

    22,597

    11,873

    R197

    Diarrhea, unspecified

    14,991

    11,730

    G4700

    Insomnia, unspecified

    17,324

    11,730

    J45909

    Unspecified asthma, uncomplicated

    20,679

    11,468

    Z515

    Encounter for palliative care

    12,883

    11,378

    J9601

    Acute respiratory failure with hypoxia

    13,339

    11,292

    D509

    Iron deficiency anemia, unspecified

    17,448

    11,275

    M1990

    Unspecified osteoarthritis, unspecified site

    16,880

    10,826

    R339

    Retention of urine, unspecified

    13,112

    10,722

    M810

    Age-related osteoporosis without current pathological fracture

    21,191

    10,711

    R0789

    Other chest pain

    13,580

    10,639

    R0902

    Hypoxemia

    12,387

    10,591

    Z86718

    Personal history of other venous thrombosis and embolism

    25,265

    10,588

    J45998

    Other asthma

    19,832

    10,580

    E861

    Hypovolemia

    11,498

    10,150

    M109

    Gout, unspecified

    22,495

    10,101

    Y848

    Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

    11,442

    9,782

    Z8249

    Family history of ischemic heart disease and other diseases of the circulatory system

    11,916

    9,767

    E1165

    Type 2 diabetes mellitus with hyperglycemia

    16,359

    9,704

    R45851

    Suicidal ideations

    17,489

    9,644

    Z951

    Presence of aortocoronary bypass graft

    24,691

    9,521

    I5032

    Chronic diastolic (congestive) heart failure

    19,145

    9,487

    R112

    Nausea with vomiting, unspecified

    12,016

    9,384

    I110

    Hypertensive heart disease with heart failure

    15,711

    9,191

    N183

    Chronic kidney disease, stage 3 (moderate)

    16,119

    9,026

    Y92230

    Patient room in hospital as the place of occurrence of the external cause

    10,288

    9,019

    Z781

    Physical restraint status

    10,069

    9,019

    R55

    Syncope and collapse

    10,258

    8,983

    Z9181

    History of falling

    11,453

    8,959

    E8339

    Other disorders of phosphorus metabolism

    10,410

    8,826

    R000

    Tachycardia, unspecified

    10,298

    8,822

    W19XXXA

    Unspecified fall, initial encounter

    9,859

    8,772

    F05

    Delirium due to known physiological condition

    9,793

    8,712

    Z006

    Encounter for examination for normal comparison and control in clinical research program

    9,558

    8,593

    E870

    Hyperosmolality and hypernatremia

    10,095

    8,588

    G92

    Toxic encephalopathy

    10,272

    8,527

    I214

    Non-ST elevation (NSTEMI) myocardial infarction

    10,280

    8,388

    E6601

    Morbid (severe) obesity due to excess calories

    14,551

    8,087

    R6521

    Severe sepsis with septic shock

    8,969

    8,040

    Z9861

    Coronary angioplasty status

    17,023

    7,972

    J690

    Pneumonitis due to inhalation of food and vomit

    9,400

    7,957

    M549

    Dorsalgia, unspecified

    10,628

    7,891

    I5033

    Acute on chronic diastolic (congestive) heart failure

    13,625

    7,817

    I480

    Paroxysmal atrial fibrillation

    13,399

    7,803

    E1122

    Type 2 diabetes mellitus with diabetic chronic kidney disease

    18,564

    7,774

    G43909

    Migraine, unspecified, not intractable, without status migrainosus

    12,782

    7,731

    I5022

    Chronic systolic (congestive) heart failure

    14,474

    7,710

    Y92239

    Unspecified place in hospital as the place of occurrence of the external cause

    8,253

    7,539

    de-identified

    Data Dictionary

    1. Discrete Copy Number Data

    Field
    Required?
    Description

    Hugo_Symbol

    Required*

    HUGO gene symbol (*one of Hugo_Symbol or Entrez_Gene_Id required)

    Entrez_Gene_Id

    Field
    Required?
    Description

    . Link does not work from cBioPortal.

    Field
    Required?
    Description
    Field
    Required?
    Description
    Field
    Required?
    Description
    Field
    Required?
    Description

    Two-dimensional matrix: one row per antibody, one column per sample. Values are log2 protein expression levels or Z-scores.

    Field
    Required?
    Description
    Field
    Required?
    Description

    This format is deprecated. New studies should use the Structural Variant (SV) format above.

    Field
    Required?
    Description
    Field
    Required?
    Description
    Field
    Required?
    Description
    Field
    Required?
    Description
    Field
    Required?
    Description
    Field
    Required?
    Description
    Field
    Required?
    Description

    Required*

    Entrez Gene numeric identifier (*one of Hugo_Symbol or Entrez_Gene_Id required)

    [SAMPLE_ID columns]

    Required

    A sample ID. This field can only contain numbers, letters, points, underscores and hyphens.

    cbp_driver

    Optional

    Custom driver annotation: Putative_Driver, Putative_Passenger, Unknown, NA

    cbp_driver_annotation

    Optional

    Free-text description of driver annotation (max 80 chars). *This field must be present if the cbp_driver is also present in the MAF file

    cbp_driver_tiers

    Optional

    Driver tier label, e.g. 'Highly actionable' (max 20 chars). *This field must be present if the cbp_driver_tiers_annotation is also present in the MAF file

    cbp_driver_tiers_annotation

    Optional

    Description of driver tier (max 80 chars). *This field must be present if the cbp_driver_tiers is also present in the MAF file

    Hugo_Symbol

    Required*

    HUGO gene symbol (*one of Hugo_Symbol or Entrez_Gene_Id required)

    Entrez_Gene_Id

    Required*

    Entrez Gene numeric identifier (*one of Hugo_Symbol or Entrez_Gene_Id required)

    ID

    Required

    Sample identifier

    chrom

    Required

    Index of the chromosome column

    Hugo_Symbol

    Recommended*

    HUGO gene symbol (*one of Hugo_Symbol or Entrez_Gene_Id required)

    Entrez_Gene_Id

    Recommended*

    Entrez Gene numeric identifier (preferred; reduces ambiguity)

    Hugo_Symbol

    Required

    A HUGO gene symbol.

    Entrez_Gene_Id

    Recommended

    A Entrez Gene numeric identifier.

    Hugo_Symbol

    Required*

    HUGO gene symbol (*one of Hugo_Symbol or Entrez_Gene_Id required)

    Entrez_Gene_Id

    Required*

    Entrez Gene numeric identifier (*one of Hugo_Symbol or Entrez_Gene_Id required)

    Composite.Element.REF

    Required

    Antibody identifier encoding gene symbol(s)/Entrez ID(s) and antibody ID, e.g. 'BRAF|B-Raf-M-NA' or 'MAPK1 MAPK3|MAPK_PT202_Y204'

    [SAMPLE_ID columns]

    Required

    One column per sample; real-number protein level per antibody-sample pair

    Sample_Id

    Required

    Sample identifier as defined in the clinical sample file

    SV_Status

    Required

    SOMATIC or GERMLINE

    Hugo_Symbol

    Required

    HUGO gene symbol

    Entrez_Gene_Id

    Required

    Entrez Gene numeric identifier

    PATIENT_ID

    Required

    Patient identifier from the dataset

    START_DATE

    Required

    Days from date of diagnosis (day 0) to event start

    chromosome

    Required

    Chromosome number (without 'chr' prefix)

    peak_start

    Required

    Start coordinate of the region of maximal amplification or deletion

    rank

    Required

    Gene rank by significance

    gene

    Required

    HUGO gene symbol

    SAMPLE_ID

    Required

    Sample identifier

    [stable_id columns]

    Required

    One column per genetic profile (e.g. 'mutations', 'gistic'); value is gene panel stable_id or NA if not profiled

    geneset_id

    Required

    Gene set name (uppercase); must match across score and p-value files

    [SAMPLE_ID columns]

    Required

    Score file: GSVA score between -1.0 and 1.0, or NA. P-value file: p-value for the score

    entity_stable_id

    Required

    Stable identifier for the assay entity (e.g. '1p', '1q', 'SBS1' for mutational signatures)

    Name

    Required

    A column from generic_entity_meta_properties (using the property name as the column header)

    2. Continuous Copy Number Data

    3. Segmented Data (SEG)

    4. Expression Data (mRNA / microRNA)

    5. Mutation Data (MAF)

    6. Methylation Data

    7. Protein Level Data (RPPA / Mass Spectrometry)

    8. Structural Variant Data (SV)

    9. Fusion Data (DEPRECATED — use Structural Variant Data instead)

    10. Timeline Data

    11. GISTIC 2.0 Data

    12. MutSig Data

    13. Gene Panel Data (Gene Panel Matrix)

    14. Gene Set Data (GSVA Scores and P-values)

    15. Generic Assay Data (incl. Arm-Level CNA, Mutational Signatures)

    Should follow this format

    [SAMPLE_ID columns]

    Required

    One column per sample; continuous copy number or log2 value per gene-sample pair

    loc.start

    Required

    Index of the start position column

    loc.end

    Required

    Index of the end position column

    num.mark

    Required

    Index of a probe or description column

    seg.mean

    Required

    No description provided (might be under the data tab on )

    [SAMPLE_ID columns]

    Required

    One column per sample; real-number expression value or NA per gene-sample pair

    Center

    Optional

    The sequencing center.

    NCBI_Build

    Required

    Genome Reference Consortium Build used by variant calling software. Must be GRCh37 or GRCh38 for human, GRCm38 for mouse.

    Chromosome

    Required

    A chromosome number, e.g. '7'.

    Start_Position

    Recommended

    Start position of the event. Required for Cancer Hotspots annotations.

    End_Position

    Recommended

    End position of the event. Required for Cancer Hotspots annotations.

    Strand

    Optional

    Strand of the mutation. Assumed to be reported for the + strand.

    Variant_Classification

    Required

    Translational effect of variant allele, e.g. Missense_Mutation, Nonsense_Mutation, Silent, Splice_Site, Frame_Shift_Del, etc. (TCGA MAF values).

    Variant_Type

    Optional

    Variant type, e.g. SNP, DNP, INS, DEL, etc.

    Reference_Allele

    Required

    The plus strand reference allele at this position.

    Tumor_Seq_Allele1

    Optional

    Primary data genotype (allele 1).

    Tumor_Seq_Allele2

    Required

    Primary data genotype (variant allele).

    dbSNP_RS

    Optional

    Latest dbSNP rs ID for this position.

    dbSNP_Val_Status

    Optional

    dbSNP validation status.

    Tumor_Sample_Barcode

    Required

    Sample ID — either a TCGA barcode (patient ID extracted automatically) or a literal SAMPLE_ID from the clinical data file.

    Matched_Norm_Sample_Barcode

    Optional

    Sample ID for the matched normal sample.

    Match_Norm_Seq_Allele1

    Optional

    Primary data genotype for matched normal (allele 1).

    Match_Norm_Seq_Allele2

    Optional

    Primary data genotype for matched normal (allele 2).

    Tumor_Validation_Allele1

    Optional

    Secondary data from orthogonal technology (tumor allele 1).

    Tumor_Validation_Allele2

    Optional

    Secondary data from orthogonal technology (tumor allele 2).

    Match_Norm_Validation_Allele1

    Optional

    Secondary data from orthogonal technology (normal allele 1).

    Match_Norm_Validation_Allele2

    Optional

    Secondary data from orthogonal technology (normal allele 2).

    Verification_Status

    Optional

    Second pass results from independent attempt using same methods. Values: Verified, Unknown, or NA.

    Validation_Status

    Optional

    Second pass results from orthogonal technology. Values: Valid, Invalid, Untested, Inconclusive, Redacted, Unknown, or NA.

    Mutation_Status

    Optional

    Somatic or Germline are displayed in the Mutations tab. None, LOH, and Wildtype will not be loaded. Other values displayed as text.

    Sequencing_Phase

    Optional

    Indicates current sequencing phase.

    Sequence_Source

    Optional

    Molecular assay type used to produce the analytes used for sequencing.

    Validation_Method

    Optional

    The assay platforms used for the validation call.

    Score

    Optional

    Not used by cBioPortal.

    BAM_File

    Optional

    Not used by cBioPortal.

    Sequencer

    Optional

    Instrument used to produce primary data.

    HGVSp_Short

    Required

    Amino acid change in HGVS notation, e.g. p.V600E.

    t_alt_count

    Optional

    Variant allele count (tumor).

    t_ref_count

    Optional

    Reference allele count (tumor).

    n_alt_count

    Optional

    Variant allele count (normal).

    n_ref_count

    Optional

    Reference allele count (normal).

    cbp_driver

    Optional

    Custom driver annotation: Putative_Driver, Putative_Passenger, Unknown, NA, or empty.

    cbp_driver_annotation

    Optional

    Free-text description of the driver annotation (max 80 chars).

    cbp_driver_tiers

    Optional

    Driver tier label, e.g. 'Highly actionable' (max 20 chars).

    cbp_driver_tiers_annotation

    Optional

    Description of the driver tier value (max 80 chars).

    ASCN.ASCN_METHOD

    Optional (ASCN)

    Method used to obtain allele-specific copy number data, e.g. FACETS.

    ASCN.CCF_EXPECTED_COPIES

    Optional (ASCN)

    Cancer-cell fraction if mutation exists on major allele.

    ASCN.CCF_EXPECTED_COPIES_UPPER

    Optional (ASCN)

    Upper error bound for cancer-cell fraction estimate.

    ASCN.EXPECTED_ALT_COPIES

    Optional (ASCN)

    Estimated number of copies harboring the mutant allele.

    ASCN.CLONAL

    Optional (ASCN)

    Clonal status: Clonal, Subclonal, or Indeterminate.

    ASCN.TOTAL_COPY_NUMBER

    Optional (ASCN)

    Total copy number of the gene.

    ASCN.MINOR_COPY_NUMBER

    Optional (ASCN)

    Copy number of the minor allele.

    ASCN.ASCN_INTEGER_COPY_NUMBER

    Optional (ASCN)

    Absolute integer copy-number estimate.

    Site2_Region

    Recommended

    Region type: 5_Prime_UTR, 3_Prime_UTR, Promoter, Exon, or Intron

    Site2_Chromosome

    Recommended

    Chromosome of gene 2

    Site2_Position

    Recommended

    Genomic position of breakpoint at gene 2

    NCBI_Build

    Optional

    Genome reference build: GRCh37 or GRCh38

    Class

    Optional

    Deletion, Duplication, Insertion, Inversion, or Translocation

    Event_Info

    Optional

    Free-text description of the event, e.g. 'TMPRSS2-ERG fusion'

    Annotation

    Optional

    Free-text description of the gene/transcript rearrangement

    Site1_Ensembl_Transcript_Id

    Optional

    Ensembl transcript ID of gene 1 (required for SV tab visualization)

    Site2_Ensembl_Transcript_Id

    Optional

    Ensembl transcript ID of gene 2 (required for SV tab visualization)

    DNA_Support

    Optional

    Yes or No — fusion detected from DNA data

    RNA_Support

    Optional

    Yes or No — fusion detected from RNA data

    SV_Length

    Optional

    Length of the structural variant in bases

    Tumor_Split_Read_Count

    Optional

    Number of split reads supporting the call in tumor

    Tumor_Paired_End_Read_Count

    Optional

    Number of paired-end reads supporting the call in tumor

    Comments

    Optional

    Any free-text comments

    [SAMPLE_ID columns]

    Required

    One column per sample; methylation beta-value per gene-sample pair

    Site1_Hugo_Symbol

    Recommended

    HUGO gene symbol of gene 1 (left/3' site)

    Site1_Ensembl_Transcript_Id

    Optional

    Ensembl transcript ID of gene 1 (required for SV tab visualization)

    Site1_Entrez_Gene_Id

    Recommended

    Entrez Gene identifier of gene 1

    Site1_Region_Number

    Recommended

    Region number of Site 1, e.g. exon 2

    Site1_Region

    Recommended

    Region type: 5_Prime_UTR, 3_Prime_UTR, Promoter, Exon, or Intron

    Site1_Chromosome

    Recommended

    Chromosome of gene 1

    Site1_Contig

    Optional

    The contig of Site 1

    Site1_Position

    Recommended

    Genomic position of breakpoint at gene 1

    Site1_Description

    Optional

    Description of this event at site 2. This could be the location of the 2nd breakpoint in case of a fusion event.

    Site2_Hugo_Symbol

    Recommended

    HUGO gene symbol of gene 2 (right/5' site)

    Site2_Ensembl_Transcript_Id

    Optional

    Ensembl transcript ID of gene 2 (required for SV tab visualization)

    Site2_Entrez_Gene_Id

    Recommended

    Entrez Gene identifier of gene 2

    Site2_Region_Number

    Recommended

    Region number of Site 2

    Site2_Region

    Recommended

    Region type: 5_Prime_UTR, 3_Prime_UTR, Promoter, Exon, or Intron

    Site2_Chromosome

    Recommended

    Chromosome of gene 2

    Site2_Contig

    Optional

    The contig of Site 2

    Site2_Position

    Recommended

    Genomic position of breakpoint at gene 2

    Site2_Description

    Optional

    Description of this event at site 1. This could be the location of the 1st breakpoint in case of a fusion event.

    Site2_Effect_On_Frame

    Optional

    The effect of frame reading in gene 2. Frame_shift or InFrame (free text)

    NCBI_Build

    Optional

    Genome reference build: GRCh37 or GRCh38

    Class

    Optional

    Deletion, Duplication, Insertion, Inversion, or Translocation

    Tumor_Split_Read_Count

    Optional

    Number of split reads supporting the call in tumor

    Tumor_Paired_End_Read_Count

    Optional

    Number of paired-end reads supporting the call in tumor

    Event_Info

    Optional

    Free-text description of the event, e.g. 'TMPRSS2-ERG fusion'

    Connection_Type

    Optional

    Which direction the connection is made

    Breakpoint_Type

    Optional

    PRECISE or IMPRECISE which explain the resolution. Fill in PRECISE if the breakpoint resolution is known down to the base pair

    Annotation

    Optional

    Free-text description of the gene/transcript rearrangement

    DNA_Support

    Optional

    Yes or No — fusion detected from DNA data

    RNA_Support

    Optional

    Yes or No — fusion detected from RNA data

    SV_Length

    Optional

    Length of the structural variant in bases

    Normal_Read_Count

    Optional

    The total number of reads of the normal tissue.

    Tumor_Read_Count

    Optional

    The total number of reads of the tumor tissue.

    Normal_Variant_Count

    Optional

    The number of reads of the normal tissue that have the variant/allele.

    Tumor_Variant_Count

    Optional

    The number of reads of the tumor tissue that have the variant/allele.

    Normal_Paired_End_Read_Count

    Optional

    The number of paired-end reads of the normal tissue that support the call.

    Normal_Split_Read_Count

    Optional

    The number of split reads of the normal tissue that support the call.

    Comments

    Optional

    Any free-text comments

    Center

    Required

    Sequencing center

    Tumor_Sample_Barcode

    Required

    Sample ID

    Fusion

    Required

    Description of the fusion, e.g. 'TMPRSS2-ERG fusion'

    DNA_support

    Required

    Fusion detected from DNA: yes or no

    RNA_support

    Required

    Fusion detected from RNA: yes or no

    Method

    Required

    Algorithm/tool used for fusion detection

    Frame

    Required

    in-frame or frameshift

    Fusion_Status

    Optional

    Assesment of mutation type: SOMATIC, GERMLINE, UNKNOWN, or empty.

    STOP_DATE

    Required

    Days from date of diagnosis to event end (blank if point-in-time event)

    EVENT_TYPE

    Required

    Category of event: TREATMENT, LAB_TEST, IMAGING, STATUS, SPECIMEN, or any custom type

    TREATMENT_TYPE

    Optional

    For TREATMENT events: Medical Therapy or Radiation Therapy

    SUBTYPE

    Optional

    For TREATMENT events: Chemotherapy, Hormone Therapy, Targeted Therapy, etc.

    AGENT

    Optional

    For TREATMENT events: agent name with number of cycles if applicable

    TEST

    Optional

    For LAB_TEST events: type of test performed

    RESULT

    Optional

    For LAB_TEST events: corresponding test result value

    DIAGNOSTIC_TYPE

    Optional

    For IMAGING events: diagnostic tool used (MRI, CT scan, etc.)

    STATUS

    Optional

    For STATUS events: best response or disease progression stage

    SPECIMEN_SITE

    Optional

    For SPECIMEN events: site from which specimen was collected

    SPECIMEN_TYPE

    Optional

    For SPECIMEN events: tissue or blood

    STYLE_SHAPE

    Optional

    Render shape for this event: circle, square, triangle, diamond, star, or camera

    STYLE_COLOR

    Optional

    Hexadecimal color value for rendering this event, e.g. #ffffff

    Agent_Class

    Optional

    Suggested for TREATMENT events to classify agents into groups

    Diagnostic_Type_Detailed

    Optional

    Suggested for IMAGING events as a detailed description

    Source

    Optional

    Appears as a suggested column for IMAGING, STATUS, and SPECIMEN events

    peak_end

    Required

    End coordinate of the region of maximal amplification or deletion

    genes_in_region

    Required

    Comma-separated list of HUGO gene symbols in the wide peak

    amp

    Required

    1 for amplification, 0 for deletion

    cytoband

    Required

    Cytogenetic band specification including chromosome (Giemsa stain)

    q_value

    Required

    Q-value (FDR-corrected p-value) of the peak region

    N (or Nnon)

    Required

    Number of bases covered

    n (or nnon)

    Required

    Number of mutations observed

    p

    Required

    P-value: probability mutations are due to background processes

    q

    Required

    Q-value: p-value corrected for multiple testing

    Description

    Required

    Another generic_entity_meta_properties column

    URL

    Required

    Another generic_entity_meta_properties column

    [SAMPLE_ID columns]

    Required

    One column per sample; numeric value per entity-sample pair

    IGV.org

    Data Counts

    1. Age

    Question
    Code
    Value
    Count
    Percent (%)

    How old were you when you had sexual intercourse for

    Q49

    1

    Question
    Code
    Value
    Count
    Percent (%)
    Question
    Code
    Value
    Count
    Percent (%)
    Question
    Code
    Value
    Count
    Percent (%)
    Question
    Code
    Value
    Count
    Percent (%)
    Question
    Code
    Value
    Count
    Percent (%)
    Question
    Code
    Value
    Count
    Percent (%)
    Question
    Code
    Value
    Count
    Percent (%)
    Question
    Code
    Value
    Count
    Percent (%)
    Question
    Code
    Value
    Count
    Percent (%)

    148809

    66.8378

    How old were you when you tried marijuana for the first time?

    Q46

    1

    133816

    60.1037

    How old were you when you tried marijuana for the first time?

    Q36

    1

    133363

    59.9002

    How old were you when you smoked a whole cigarette

    Q25

    2

    104615

    46.988

    How old were you when you first started smoking

    Q27

    1

    97632

    43.8516

    How old were you when you had your first drink of alcohol other than

    Q40

    1

    95370

    42.8356

    How old were you when you had sexual intercourse for the first time?

    Q58

    1

    90869

    40.814

    How old were you when you smoked a whole cigarette

    Q25

    1

    69859

    31.3773

    How old were you when you first started smoking

    Q27

    <missing>

    62654

    28.1411

    How old were you when you had sexual intercourse for the first time?

    Q58

    2

    57567

    25.8563

    How old were you when you had sexual intercourse for

    Q49

    <missing>

    54754

    24.5928

    How old are you?

    Q1

    5

    51555

    23.156

    How old are you?

    Q1

    6

    51323

    23.0518

    How old were you when you tried marijuana for the

    Q36

    <missing>

    47463

    21.3181

    How old are you?

    Q1

    4

    46293

    20.7926

    How old were you when you first started smoking

    Q27

    2

    42753

    19.2026

    How old were you when you smoked a whole cigarette

    Q25

    <missing>

    40160

    18.0379

    How old were you when you tried marijuana for the first time?

    Q46

    <missing>

    40087

    18.0051

    How old were you when you had sexual intercourse for the first time?

    Q58

    <missing>

    33931

    15.2402

    How old were you when you had your first drink of alcohol other than

    Q40

    <missing>

    31177

    14.0032

    How old are you?

    Q1

    7

    30584

    13.7369

    How old were you when you had your first drink of alcohol other than

    Q40

    5

    23180

    10.4113

    How old are you?

    Q1

    3

    21452

    9.6352

    How old are you?

    Q1

    <missing>

    20776

    9.3316

    How old were you when you had your first drink of alcohol other than

    Q40

    6

    19383

    8.7059

    How old were you when you had your first drink of alcohol other than

    Q40

    2

    18478

    8.2994

    How old were you when you had your first drink of alcohol other than

    Q40

    4

    14115

    6.3398

    How old were you when you had your first drink of alcohol other than

    Q40

    3

    13939

    6.2607

    How old were you when you tried marijuana for the first time?

    Q46

    6

    12007

    5.393

    How old were you when you tried marijuana for the first time?

    Q46

    5

    10911

    4.9007

    How old were you when you tried marijuana for the

    Q36

    5

    10211

    4.5863

    How old were you when you tried marijuana for the

    Q36

    2

    9800

    4.4017

    How old were you when you tried marijuana for the first time?

    Q46

    2

    8566

    3.8474

    How old were you when you had sexual intercourse for the first time?

    Q58

    7

    8301

    3.7284

    How old were you when you had sexual intercourse for the first time?

    Q58

    4

    8072

    3.6256

    How old were you when you had sexual intercourse for the first time?

    Q58

    3

    7255

    3.2586

    How old were you when you had sexual intercourse for the first time?

    Q58

    5

    7133

    3.2038

    How old were you when you had sexual intercourse for the first time?

    Q58

    6

    7130

    3.2025

    How old were you when you had your first drink of alcohol other than

    Q40

    7

    7000

    3.1441

    How old were you when you tried marijuana for the

    Q36

    3

    6873

    3.087

    How old were you when you had sexual intercourse for

    Q49

    2

    6673

    2.9972

    How old were you when you tried marijuana for the

    Q36

    6

    6497

    2.9181

    How old were you when you tried marijuana for the first time?

    Q46

    3

    6397

    2.8732

    How old were you when you first started smoking

    Q27

    5

    5736

    2.5763

    How old were you when you tried marijuana for the

    Q36

    4

    5677

    2.5498

    How old were you when you tried marijuana for the first time?

    Q46

    4

    5453

    2.4492

    How old were you when you first started smoking

    Q27

    3

    5311

    2.3854

    How old were you when you tried marijuana for the first time?

    Q46

    7

    4585

    2.0594

    How old were you when you first started smoking

    Q27

    6

    3954

    1.7759

    How old were you when you first started smoking

    Q27

    4

    3657

    1.6425

    How old were you when you had sexual intercourse for

    Q49

    3

    3524

    1.5828

    How old were you when you had sexual intercourse for

    Q49

    6

    2884

    1.2954

    How old were you when you smoked a whole cigarette

    Q25

    3

    2684

    1.2055

    How old were you when you had sexual intercourse for

    Q49

    4

    2324

    1.0438

    How old were you when you smoked a whole cigarette

    Q25

    5

    2229

    1.0012

    How old were you when you tried marijuana for the

    Q36

    7

    2114

    0.9495

    How old were you when you had sexual intercourse for

    Q49

    5

    2027

    0.9104

    How old were you when you smoked a whole cigarette

    Q25

    4

    1449

    0.6508

    How old were you when you smoked a whole cigarette

    Q25

    6

    1300

    0.5839

    How old were you when you had sexual intercourse for

    Q49

    7

    1057

    0.4748

    How old were you when you first started smoking

    Q27

    7

    945

    0.4244

    How old are you?

    Q1

    1

    371

    0.1666

    How old were you when you smoked a whole cigarette

    Q25

    7

    346

    0.1554

    How old are you?

    Q1

    2

    287

    0.1289

    the past 7 days, how many times did you drink a can, bottle, orQ95 glass of a sports drink such as Gatorade or PowerAde?

    During

    <missing>

    210733

    94.6511

    During your life, how many times have you used heroin (also called

    Q52

    1

    185111

    83.1429

    Among students who had sexual intercourse during the past

    QNBCNONE

    <missing>

    208535

    93.6638

    How tall are you without your shoes on? (Note: Data are in meters.)

    Q6

    1

    24558

    11.0303

    During your life, how many times have you used synthetic marijuana?

    Q48

    1

    150532

    67.6117

    Percentage of students who actually attempted suicide (one or more

    QN28

    <missing>

    129206

    58.0331

    Race as originally scanned

    RACEORIG

    <missing>

    212726

    95.5462

    During the past 30 days, on how many days did you smoke cigars,

    Q38

    1

    170175

    76.4344

    Weight_2

    Weight_2

    <missing>

    208725

    93.7492

    2. Alcohol Use

    3. Drug Use

    4. Gender

    5. Height

    6. Marijuana Use

    7. Mental Health

    8. Race

    9. Tobacco Use

    10. Weight

    During the past 30 days, how did you usually get the alcohol you

    Q44

    1

    142858

    64.1649

    During the past 30 days, how did you usually get the alcohol you

    Q45

    1

    136813

    61.4498

    Percentage of students who had their first drink of alcohol

    QN40

    <missing>

    134826

    60.5573

    Percentage of students who had at least one drink of alcohol

    QN39

    <missing>

    126782

    56.9443

    Percentage of students who drank alcohol or used drugs before last

    QN61

    <missing>

    123381

    55.4168

    During the past 7 days, how many times did you drink a can, bottle, or

    Q90

    <missing>

    118346

    53.1553

    Percentage of students who had five or more drinks of

    QN42

    2

    95886

    43.0673

    Percentage of students who had five or more drinks of

    QN42

    <missing>

    93935

    42.1911

    Percentage of students who currently drank alcohol (at least one drink

    QN41

    <missing>

    89242

    40.0832

    Percentage of students who currently drank alcohol (at least one drink

    QN41

    2

    87479

    39.2913

    Percentage of students who drank alcohol or used drugs before last

    QN61

    2

    66438

    29.8407

    Percentage of students who had their first drink of alcohol

    QN40

    2

    59933

    26.919

    Percentage of students who had at least one drink of alcohol

    QN39

    2

    54900

    24.6584

    During the past 7 days, how many times did you drink a can, bottle, or

    Q90

    1

    52140

    23.4188

    Percentage of students who currently drank alcohol (at least one drink

    QN41

    1

    42467

    19.0741

    During the past 30 days, how did you usually get the alcohol you

    Q44

    <missing>

    37002

    16.6195

    Percentage of students who had at least one drink of alcohol

    QN39

    1

    35427

    15.9121

    Percentage of students who had five or more drinks of

    QN42

    1

    30084

    13.5123

    During the past 7 days, how many times did you drink a can, bottle, or

    Q90

    2

    27199

    12.2165

    Percentage of students who had their first drink of alcohol

    QN40

    1

    24703

    11.0954

    During the past 30 days, how did you usually get the alcohol you

    Q45

    2

    21835

    9.8072

    During the past 30 days, how did you usually get the alcohol you

    Q45

    <missing>

    19565

    8.7877

    Percentage of students who drank alcohol or used drugs before last

    QN61

    1

    19535

    8.7742

    Percentage of students who drank alcohol or used drugs before last

    QN61

    .

    13288

    5.9683

    During the past 30 days, how did you usually get the alcohol you

    Q45

    6

    11459

    5.1468

    During the past 30 days, how did you usually get the alcohol you

    Q45

    5

    11315

    5.0821

    During the past 30 days, how did you usually get the alcohol you

    Q44

    2

    10119

    4.545

    During the past 7 days, how many times did you drink a can, bottle, or

    Q90

    3

    8254

    3.7073

    During the past 30 days, how did you usually get the alcohol you

    Q45

    7

    7292

    3.2752

    During the past 30 days, how did you usually get the alcohol you

    Q44

    6

    7058

    3.1701

    During the past 30 days, how did you usually get the alcohol you

    Q44

    3

    7026

    3.1557

    During the past 30 days, how did you usually get the alcohol you

    Q44

    7

    6823

    3.0646

    During the past 30 days, how did you usually get the alcohol you

    Q45

    3

    6370

    2.8611

    During the past 30 days, how did you usually get the alcohol you

    Q45

    4

    6138

    2.7569

    Percentage of students who had at least one drink of alcohol

    QN39

    .

    5533

    2.4852

    the past 7 days, how many times did you drink a can, bottle, orQ95 glass of a sports drink such as Gatorade or PowerAde?

    During

    1

    5359

    2.407

    During the past 30 days, how did you usually get the alcohol you

    Q44

    5

    5290

    2.376

    During the past 7 days, how many times did you drink a can, bottle, or

    Q90

    4

    4978

    2.2359

    During the past 30 days, how did you usually get the alcohol you

    Q44

    4

    4244

    1.9062

    During the past 7 days, how many times did you drink a can, bottle, or

    Q90

    5

    3845

    1.727

    the past 7 days, how many times did you drink a can, bottle, orQ95 glass of a sports drink such as Gatorade or PowerAde?

    During

    2

    3754

    1.6861

    Percentage of students who currently drank alcohol (at least one drink

    QN41

    .

    3454

    1.5514

    During the past 7 days, how many times did you drink a can, bottle, or

    Q90

    6

    3364

    1.5109

    Percentage of students who had their first drink of alcohol

    QN40

    .

    3180

    1.4283

    Percentage of students who had five or more drinks of

    QN42

    .

    2737

    1.2293

    During the past 7 days, how many times did you drink a can, bottle, or

    Q90

    8

    2561

    1.1503

    the past 7 days, how many times did you drink a can, bottle, orQ95 glass of a sports drink such as Gatorade or PowerAde?

    During

    3

    1306

    0.5866

    the past 7 days, how many times did you drink a can, bottle, orQ95 glass of a sports drink such as Gatorade or PowerAde?

    During

    4

    642

    0.2884

    the past 7 days, how many times did you drink a can, bottle, orQ95 glass of a sports drink such as Gatorade or PowerAde?

    During

    5

    358

    0.1608

    the past 7 days, how many times did you drink a can, bottle, orQ95 glass of a sports drink such as Gatorade or PowerAde?

    During

    7

    301

    0.1352

    the past 7 days, how many times did you drink a can, bottle, orQ95 glass of a sports drink such as Gatorade or PowerAde?

    During

    6

    189

    0.0849

    During your life, how many times have you used ecstasy (also called

    Q54

    1

    151349

    67.9786

    During your life, how many times have you used methamphetamines

    Q53

    1

    150263

    67.4909

    Percenta ge of students who used ecstasy one or more times

    QN54

    <missing>

    123874

    55.6382

    Percent age of students who used heroin one or more times

    QN52

    <missing>

    123701

    55.5605

    Percentage of students who were offered, sold, or given an illegal drug

    QN56

    <missing>

    119726

    53.7751

    Percentage of students who took steroid pills or shots

    QN55

    <missing>

    114377

    51.3726

    During your life, how many times have you used hallucinogenic drugs,

    Q89

    <missing>

    110390

    49.5818

    "speed," "crystal meth," "crank," "ice," or "meth," one or more times

    QN53

    2

    109473

    49.17

    "speed," "crystal meth," "crank," "ice," or "meth," one or more times

    QN53

    <missing>

    106830

    47.9829

    Percent age of students who used any form of cocaine,

    QN49

    <missing>

    106382

    47.7816

    Percent age of students who used any form of cocaine,

    QN49

    2

    103125

    46.3188

    Percentage of students who took steroid pills or shots

    QN55

    2

    102686

    46.1216

    Percent age of students who used heroin one or more times

    QN52

    2

    93379

    41.9413

    Percenta ge of students who used ecstasy one or more times

    QN54

    2

    91802

    41.233

    Percentage of students who were offered, sold, or given an illegal drug

    QN56

    2

    90106

    40.4712

    During your life, how many times have you used hallucinogenic drugs,

    Q89

    1

    60279

    27.0744

    During your life, how many times have you used ecstasy (also called

    Q54

    <missing>

    41978

    18.8545

    During your life, how many times have you used methamphetamines

    Q53

    2

    40252

    18.0792

    During your life, how many times have you used hallucinogenic drugs,

    Q89

    2

    25622

    11.5082

    During your life, how many times have you used methamphetamines

    Q53

    <missing>

    25328

    11.3761

    During your life, how many times have you used heroin (also called

    Q52

    <missing>

    24662

    11.077

    During your life, how many times have you used ecstasy (also called

    Q54

    2

    19334

    8.6839

    Percentage of students who were offered, sold, or given an illegal drug

    QN56

    1

    11677

    5.2447

    Percent age of students who used any form of cocaine,

    QN49

    1

    11322

    5.0853

    During your life, how many times have you used hallucinogenic drugs,

    Q89

    3

    10445

    4.6914

    During your life, how many times have you used hallucinogenic drugs,

    Q89

    4

    8857

    3.9781

    During your life, how many times have you used heroin (also called

    Q52

    3

    6656

    2.9896

    Percenta ge of students who used ecstasy one or more times

    QN54

    1

    5814

    2.6114

    During your life, how many times have you used hallucinogenic drugs,

    Q89

    5

    5595

    2.513

    During your life, how many times have you used methamphetamines

    Q53

    3

    4570

    2.0526

    "speed," "crystal meth," "crank," "ice," or "meth," one or more times

    QN53

    1

    4541

    2.0396

    Percent age of students who used heroin one or more times

    QN52

    1

    4246

    1.9071

    During your life, how many times have you used heroin (also called

    Q52

    2

    4081

    1.833

    Percentage of students who took steroid pills or shots

    QN55

    1

    3937

    1.7683

    During your life, how many times have you used ecstasy (also called

    Q54

    3

    3816

    1.714

    During your life, how many times have you used ecstasy (also called

    Q54

    4

    3386

    1.5208

    Percent age of students who used any form of cocaine,

    QN49

    .

    1813

    0.8143

    "speed," "crystal meth," "crank," "ice," or "meth," one or more times

    QN53

    .

    1798

    0.8076

    Percentage of students who took steroid pills or shots

    QN55

    .

    1642

    0.7375

    During your life, how many times have you used ecstasy (also called

    Q54

    5

    1448

    0.6504

    Percent age of students who used heroin one or more times

    QN52

    .

    1316

    0.5911

    During your life, how many times have you used ecstasy (also called

    Q54

    6

    1160

    0.521

    During your life, how many times have you used methamphetamines

    Q53

    6

    1153

    0.5179

    Percenta ge of students who used ecstasy one or more times

    QN54

    .

    1152

    0.5174

    Percentage of students who were offered, sold, or given an illegal drug

    QN56

    .

    1133

    0.5089

    During your life, how many times have you used heroin (also called

    Q52

    6

    1080

    0.4851

    During your life, how many times have you used hallucinogenic drugs,

    Q89

    7

    892

    0.4006

    During your life, how many times have you used methamphetamines

    Q53

    4

    673

    0.3023

    During your life, how many times have you used heroin (also called

    Q52

    4

    661

    0.2969

    During your life, how many times have you used methamphetamines

    Q53

    5

    403

    0.181

    During your life, how many times have you used heroin (also called

    Q52

    5

    391

    0.1756

    During your life, how many times have you used hallucinogenic drugs,

    Q89

    6

    342

    0.1536

    During your life, how many times have you used ecstasy (also called

    Q54

    7

    171

    0.0768

    Among students who had sexual intercourse during the past

    QNDUALBC

    <missing>

    208489

    93.6432

    Percentage of students who have never had sex, haven’t had

    QNRESPSX

    <missing>

    207428

    93.1666

    Percentile for body mass index, by age and sex

    BMIPct

    <missing>

    194684

    87.4426

    Among students who had sexual intercourse during the past

    QN63

    <missing>

    164705

    73.9775

    Have you ever been physically forced to have sexual intercourse when

    Q19

    1

    134269

    60.3071

    Of students who had sexual

    QN62

    <missing>

    131640

    59.1263

    Percentage of st udents who had sexual intercourse with four

    QN60

    <missing>

    125984

    56.5859

    Percentage of st udents who had sexual intercourse for the

    QN59

    <missing>

    125909

    56.5522

    Percentage of students who ever had sexual intercourse

    QN58

    <missing>

    125137

    56.2055

    touching, or being physically forced to have sexual intercourse] that

    QN20

    <missing>

    110558

    49.6573

    The last time you had sexual intercourse with an opposite-sex partner,

    Q63

    1

    106099

    47.6545

    touching, or being physically forced to have sexual intercourse] that

    QN20

    2

    98106

    44.0645

    What is your sex?

    Q2

    1

    93503

    41.997

    What is your sex?

    Q2

    2

    91077

    40.9074

    The last time you had sexual intercourse with an opposite-sex partner,

    Q62

    1

    89345

    40.1294

    Percentage of st udents who had sexual intercourse with four

    QN60

    2

    71907

    32.2971

    Percentage of st udents who had sexual intercourse for the

    QN59

    2

    71381

    32.0609

    Percentage of students who ever had sexual intercourse

    QN58

    2

    66170

    29.7204

    Have you ever been physically forced to have sexual intercourse when

    Q19

    2

    52734

    23.6856

    The last time you had sexual intercourse with an opposite-sex partner,

    Q62

    <missing>

    47794

    21.4667

    The last time you had sexual intercourse with an opposite-sex partner,

    Q63

    <missing>

    47060

    21.1371

    Of students who had sexual

    QN62

    2

    43271

    19.4352

    The last time you had sexual intercourse with an opposite-sex partner,

    Q62

    3

    40539

    18.2082

    What is your sex?

    Q2

    <missing>

    38062

    17.0956

    Of students who had sexual

    QN62

    .

    29442

    13.2239

    The last time you had sexual intercourse with an opposite-sex partner,

    Q62

    2

    29138

    13.0874

    Have you ever been physically forced to have sexual intercourse when

    Q19

    <missing>

    29104

    13.0721

    The last time you had sexual intercourse with an opposite-sex partner,

    Q63

    2

    25941

    11.6514

    Percentage of students who ever had sexual intercourse

    QN58

    1

    25482

    11.4453

    Among students who had sexual intercourse during the past

    QN63

    2

    25387

    11.4026

    The last time you had sexual intercourse with an opposite-sex partner,

    Q63

    3

    23425

    10.5214

    Percentage of st udents who had sexual intercourse for the

    QN59

    1

    20511

    9.2125

    Among students who had sexual intercourse during the past

    QN63

    .

    19574

    8.7917

    Percentage of st udents who had sexual intercourse with four

    QN60

    1

    19071

    8.5658

    Of students who had sexual

    QN62

    1

    18289

    8.2145

    The last time you had sexual intercourse with an opposite-sex partner,

    Q63

    4

    14978

    6.7274

    Among students who had sexual intercourse during the past

    QN63

    1

    12976

    5.8282

    Among students who had sexual intercourse during the past

    QNDUALBC

    2

    12891

    5.79

    touching, or being physically forced to have sexual intercourse] that

    QN20

    1

    12857

    5.7747

    Among students who had sexual intercourse during the past

    QNBCNONE

    2

    12113

    5.4406

    Percentage of students who have never had sex, haven’t had

    QNRESPSX

    1

    11200

    5.0305

    The last time you had sexual intercourse with an opposite-sex partner,

    Q62

    4

    10853

    4.8746

    Percentage of students who ever had sexual intercourse

    QN58

    .

    5853

    2.6289

    Percentage of st udents who had sexual intercourse with four

    QN60

    .

    5680

    2.5512

    Percentage of st udents who had sexual intercourse for the

    QN59

    .

    4841

    2.1743

    Have you ever been physically forced to have sexual intercourse when

    Q19

    3

    3726

    1.6735

    The last time you had sexual intercourse with an opposite-sex partner,

    Q62

    5

    2628

    1.1804

    Percentage of students who have never had sex, haven’t had

    QNRESPSX

    .

    2147

    0.9643

    Among students who had sexual intercourse during the past

    QNBCNONE

    1

    1994

    0.8956

    The last time you had sexual intercourse with an opposite-sex partner,

    Q63

    5

    1923

    0.8637

    Percentage of students who have never had sex, haven’t had

    QNRESPSX

    2

    1867

    0.8386

    Percentile for body mass index, by age and sex

    BMIPct

    .

    1777

    0.7981

    The last time you had sexual intercourse with an opposite-sex partner,

    Q63

    6

    1671

    0.7505

    Among students who had sexual intercourse during the past

    QNDUALBC

    1

    1262

    0.5668

    touching, or being physically forced to have sexual intercourse] that

    QN20

    .

    1121

    0.5035

    Have you ever been physically forced to have sexual intercourse when

    Q19

    4

    1029

    0.4622

    Percentile for body mass index, by age and sex

    BMIPct

    99

    1003

    0.4505

    The last time you had sexual intercourse with an opposite-sex partner,

    Q63

    7

    927

    0.4164

    The last time you had sexual intercourse with an opposite-sex partner,

    Q62

    6

    922

    0.4141

    Percentile for body mass index, by age and sex

    BMIPct

    98

    824

    0.3701

    The last time you had sexual intercourse with an opposite-sex partner,

    Q62

    7

    810

    0.3638

    Have you ever been physically forced to have sexual intercourse when

    Q19

    5

    765

    0.3436

    Percentile for body mass index, by age and sex

    BMIPct

    97

    694

    0.3117

    Have you ever been physically forced to have sexual intercourse when

    Q19

    8

    689

    0.3095

    Percentile for body mass index, by age and sex

    BMIPct

    96

    615

    0.2762

    Percentile for body mass index, by age and sex

    BMIPct

    95

    603

    0.2708

    Percentile for body mass index, by age and sex

    BMIPct

    94

    558

    0.2506

    Have you ever been physically forced to have sexual intercourse when

    Q19

    6

    200

    0.0898

    In what grade are you?

    Q3

    4

    46371

    20.8276

    In what grade are you?

    Q3

    3

    46302

    20.7966

    In what grade are you?

    Q3

    1

    45831

    20.5851

    In what grade are you?

    Q3

    2

    45740

    20.5442

    In what grade are you?

    Q3

    <missing>

    38121

    17.1221

    In what grade are you?

    Q3

    5

    277

    0.1244

    How tall are you without your shoes on? (Note: Data are in meters.)

    Q6

    <missing>

    22291

    10.012

    How tall are you without your shoes on? (Note: Data are in meters.)

    Q6

    2

    8056

    3.6184

    How tall are you without your shoes on? (Note: Data are in meters.)

    Q6

    4

    7989

    3.5883

    How tall are you without your shoes on? (Note: Data are in meters.)

    Q6

    5

    7904

    3.5501

    How tall are you without your shoes on? (Note: Data are in meters.)

    Q6

    1.68

    7686

    3.4522

    How tall are you without your shoes on? (Note: Data are in meters.)

    Q6

    1.63

    7486

    3.3623

    How tall are you without your shoes on? (Note: Data are in meters.)

    Q6

    1.7

    7481

    3.3601

    During the past 30 days, how many times did you use marijuana?

    Q47

    1

    146777

    65.9251

    Percentage of students who used marijuana one or more

    QN44

    <missing>

    132172

    59.3653

    Percentage of students who tried marijuana for the first time before age

    QN46

    <missing>

    128714

    57.8121

    Percentage of students who ever used marijuana (one or more times

    QN45

    <missing>

    115997

    52.1002

    Percentage of students who ever used synthetic marijuana (one or more

    QN48

    <missing>

    114057

    51.2289

    Percentage of students who currently used marijuana (one or more

    QN47

    <missing>

    106261

    47.7273

    Percentage of students who currently used marijuana (one or more

    QN47

    2

    96868

    43.5084

    Percentage of students who ever used synthetic marijuana (one or more

    QN48

    2

    94794

    42.5769

    Percentage of students who ever used marijuana (one or more times

    QN45

    2

    86953

    39.0551

    Percentage of students who tried marijuana for the first time before age

    QN46

    2

    70888

    31.8395

    Percentage of students who used marijuana one or more

    QN44

    2

    57964

    26.0346

    During your life, how many times have you used synthetic marijuana?

    Q48

    <missing>

    46881

    21.0567

    During the past 30 days, how many times did you use marijuana?

    Q47

    <missing>

    38532

    17.3067

    Percentage of students who tried marijuana for the first time before age

    QN46

    1

    21499

    9.6563

    Percentage of students who used marijuana one or more

    QN44

    1

    21055

    9.4569

    Percentage of students who ever used marijuana (one or more times

    QN45

    1

    18156

    8.1548

    Percentage of students who currently used marijuana (one or more

    QN47

    1

    18080

    8.1207

    Percentage of students who ever used synthetic marijuana (one or more

    QN48

    1

    12466

    5.5991

    Percentage of students who used marijuana one or more

    QN44

    .

    11451

    5.1432

    During your life, how many times have you used synthetic marijuana?

    Q48

    2

    10943

    4.9151

    During the past 30 days, how many times did you use marijuana?

    Q47

    2

    10854

    4.8751

    During the past 30 days, how many times did you use marijuana?

    Q47

    6

    7781

    3.4948

    During the past 30 days, how many times did you use marijuana?

    Q47

    5

    6428

    2.8871

    During the past 30 days, how many times did you use marijuana?

    Q47

    3

    5749

    2.5822

    During your life, how many times have you used synthetic marijuana?

    Q48

    6

    4511

    2.0261

    During the past 30 days, how many times did you use marijuana?

    Q47

    4

    3880

    1.7427

    During your life, how many times have you used synthetic marijuana?

    Q48

    3

    3540

    1.59

    During your life, how many times have you used synthetic marijuana?

    Q48

    5

    3290

    1.4777

    During the past 30 days, how many times did you use marijuana?

    Q47

    7

    2641

    1.1862

    During your life, how many times have you used synthetic marijuana?

    Q48

    4

    2484

    1.1157

    Percentage of students who tried marijuana for the first time before age

    QN46

    .

    1541

    0.6921

    Percentage of students who ever used marijuana (one or more times

    QN45

    .

    1536

    0.6899

    Percentage of students who currently used marijuana (one or more

    QN47

    .

    1433

    0.6436

    Percentage of students who ever used synthetic marijuana (one or more

    QN48

    .

    1325

    0.5951

    During your life, how many times have you used synthetic marijuana?

    Q48

    7

    461

    0.2071

    Percentage of students who seriously considered attempting suicide

    QN26

    <missing>

    119070

    53.4805

    Percentage of students who seriously considered attempting suicide

    QN26

    2

    82799

    37.1893

    Percentage of students who actually attempted suicide (one or more

    QN28

    2

    62797

    28.2054

    Percentage of students who actually attempted suicide (one or more

    QN28

    1

    28975

    13.0142

    Percentage of students who seriously considered attempting suicide

    QN26

    1

    15515

    6.9686

    Percentage of students who seriously considered attempting suicide

    QN26

    .

    5258

    2.3616

    Percentage of students who actually attempted suicide (one or more

    QN28

    .

    1664

    0.7474

    Race/ethnicity as originally scanned

    Q4ORIG

    <missing>

    208956

    93.8529

    Race/Ethnicity

    RaceEth

    <missing>

    208849

    93.8049

    RACEETH

    RACEETH

    <missing>

    130067

    58.4198

    What is your race?

    Q5

    E

    58300

    26.1855

    RACEETH

    RACEETH

    5

    43400

    19.4932

    What is your race?

    Q5

    C

    19353

    8.6924

    What is your race?

    Q5

    4

    15900

    7.1415

    RACEETH

    RACEETH

    3

    14709

    6.6066

    RACEETH

    RACEETH

    7

    13011

    5.8439

    What is your race?

    Q5

    <missing>

    12426

    5.5812

    What is your race?

    Q5

    3

    12027

    5.4019

    What is your race?

    Q5

    2

    9784

    4.3945

    What is your race?

    Q5

    5

    9319

    4.1856

    RACEETH

    RACEETH

    6

    8934

    4.0127

    What is your race?

    Q5

    1

    7803

    3.5047

    Race/ethnicity as originally scanned

    Q4ORIG

    F

    6122

    2.7497

    Race as originally scanned

    RACEORIG

    E

    6096

    2.738

    Race/Ethnicity

    RaceEth

    5

    5775

    2.5939

    RACEETH

    RACEETH

    8

    5630

    2.5287

    RACEETH

    RACEETH

    2

    4078

    1.8316

    Race/ethnicity as originally scanned

    Q4ORIG

    C

    3347

    1.5033

    Race/Ethnicity

    RaceEth

    3

    2931

    1.3165

    Race as originally scanned

    RACEORIG

    C

    2662

    1.1956

    RACEETH

    RACEETH

    1

    2175

    0.9769

    Race/ethnicity as originally scanned

    Q4ORIG

    D

    2069

    0.9293

    Race/Ethnicity

    RaceEth

    6

    2008

    0.9019

    Race/Ethnicity

    RaceEth

    7

    1868

    0.839

    Race/ethnicity as originally scanned

    Q4ORIG

    D F

    651

    0.2924

    Race/Ethnicity

    RaceEth

    2

    428

    0.1922

    Race/Ethnicity

    RaceEth

    8

    383

    0.172

    Race/ethnicity as originally scanned

    Q4ORIG

    B

    368

    0.1653

    Race as originally scanned

    RACEORIG

    B

    323

    0.1451

    Race as originally scanned

    RACEORIG

    A

    314

    0.141

    Race/Ethnicity

    RaceEth

    1

    297

    0.1334

    Race/ethnicity as originally scanned

    Q4ORIG

    A D

    188

    0.0844

    Race/ethnicity as originally scanned

    Q4ORIG

    A

    147

    0.066

    Race as originally scanned

    RACEORIG

    D

    125

    0.0561

    Race as originally scanned

    RACEORIG

    A E

    122

    0.0548

    Race as originally scanned

    RACEORIG

    C E

    64

    0.0287

    Percentage of students who used any tobacco during the past

    QNANYTOB

    <missing>

    151221

    67.9211

    the days they smoked during the 30 days before the survey, among

    QN33

    <missing>

    149093

    66.9654

    During the past 30 days, on how many days did you smoke cigarettes?

    Q32

    1

    129641

    58.2285

    Percentage of students who used chewing tobacco, snuff, or

    QN36

    <missing>

    128103

    57.5377

    Percent age of students who usually got their own cigarettes

    QN32

    <missing>

    124426

    55.8861

    Percentage of students who smoked cigarettes on 20 or more

    QNFRCIG

    <missing>

    124299

    55.8291

    Percent age of students who smoked a whole cigarette for the

    QN29

    <missing>

    120611

    54.1726

    (including e-cigarettes, vapes, vape pens, e-cigars, e-hookahs, hookah

    QN34

    <missing>

    117912

    52.9604

    Of st udents who are current smokers, the percentage who

    QN35

    <missing>

    117286

    52.6792

    Percent age of students who smoked cigarettes on one or

    QN30

    <missing>

    116792

    52.4573

    During the past 30 days, on the days you smoked, how many cigarettes

    Q33

    1

    112645

    50.5947

    Percentage of students who first tried cigarette smoking before age 13

    QN31

    <missing>

    110944

    49.8307

    Percentage of students who currently smoked cigars (cigars, cigarillos,

    QN38

    2

    109352

    49.1156

    During the past 12 months, did you ever try to quit using all tobacco

    Q39

    1

    106254

    47.7241

    Percentage of students who currently smoked cigars (cigars, cigarillos,

    QN38

    <missing>

    100108

    44.9637

    Have you ever smoked cigarettes regularly, that is,

    Q26

    1

    95556

    42.9191

    Percentage of students who smoked cigarettes on 20 or more

    QNFRCIG

    2

    90160

    40.4955

    Percent age of students who smoked cigarettes on one or

    QN30

    2

    84462

    37.9362

    Percent age of students who smoked a whole cigarette for the

    QN29

    2

    83702

    37.5949

    Have you ever smoked cigarettes regularly, that is,

    Q26

    2

    79194

    35.5701

    (including e-cigarettes, vapes, vape pens, e-cigars, e-hookahs, hookah

    QN34

    2

    77394

    34.7616

    Percentage of students who first tried cigarette smoking before age 13

    QN31

    2

    73716

    33.1097

    Percentage of students who used chewing tobacco, snuff, or

    QN36

    2

    71816

    32.2563

    During the past 30 days, on the days you smoked, how many cigarettes

    Q33

    <missing>

    69887

    31.3899

    During the past 30 days, on how many days did you smoke cigarettes?

    Q32

    <missing>

    57597

    25.8698

    Percent age of students who usually got their own cigarettes

    QN32

    2

    55187

    24.7873

    the days they smoked during the 30 days before the survey, among

    QN33

    2

    53302

    23.9407

    Of st udents who are current smokers, the percentage who

    QN35

    2

    50395

    22.635

    Percentage of students who used any tobacco during the past

    QNANYTOB

    2

    50196

    22.5456

    Have you ever smoked cigarettes regularly, that is,

    Q26

    <missing>

    44789

    20.117

    During the past 12 months, did you ever try to quit using all tobacco

    Q39

    <missing>

    42567

    19.119

    Percent age of students who usually got their own cigarettes

    QN32

    .

    38022

    17.0776

    Of st udents who are current smokers, the percentage who

    QN35

    .

    36165

    16.2436

    (including e-cigarettes, vapes, vape pens, e-cigars, e-hookahs, hookah

    QN34

    1

    24429

    10.9723

    Percentage of students who first tried cigarette smoking before age 13

    QN31

    .

    24388

    10.9539

    During the past 30 days, on the days you smoked, how many cigarettes

    Q33

    2

    22963

    10.3139

    Of st udents who are current smokers, the percentage who

    QN35

    1

    18796

    8.4423

    During the past 12 months, did you ever try to quit using all tobacco

    Q39

    2

    18788

    8.4387

    During the past 12 months, did you ever try to quit using all tobacco

    Q39

    3

    18727

    8.4113

    Percent age of students who smoked cigarettes on one or

    QN30

    1

    18578

    8.3443

    Percentage of students who used any tobacco during the past

    QNANYTOB

    1

    16010

    7.1909

    the days they smoked during the 30 days before the survey, among

    QN33

    .

    15290

    6.8675

    During the past 30 days, on how many days did you smoke cigars,

    Q38

    2

    14963

    6.7207

    Percentage of students who used chewing tobacco, snuff, or

    QN36

    .

    14769

    6.6335

    Percent age of students who smoked a whole cigarette for the

    QN29

    1

    14643

    6.5769

    Percentage of students who first tried cigarette smoking before age 13

    QN31

    1

    13594

    6.1058

    During the past 30 days, on how many days did you smoke cigars,

    Q38

    <missing>

    10858

    4.8769

    Percentage of students who currently smoked cigars (cigars, cigarillos,

    QN38

    1

    10347

    4.6474

    During the past 12 months, did you ever try to quit using all tobacco

    Q39

    4

    10071

    4.5234

    During the past 12 months, did you ever try to quit using all tobacco

    Q39

    5

    9261

    4.1596

    During the past 12 months, did you ever try to quit using all tobacco

    Q39

    7

    9134

    4.1026

    During the past 30 days, on how many days did you smoke cigarettes?

    Q32

    2

    8895

    3.9952

    During the past 30 days, on how many days did you smoke cigars,

    Q38

    3

    8567

    3.8479

    Percentage of students who used chewing tobacco, snuff, or

    QN36

    1

    7954

    3.5726

    During the past 12 months, did you ever try to quit using all tobacco

    Q39

    6

    7840

    3.5213

    During the past 30 days, on how many days did you smoke cigarettes?

    Q32

    5

    7573

    3.4014

    During the past 30 days, on how many days did you smoke cigars,

    Q38

    5

    6518

    2.9276

    During the past 30 days, on how many days did you smoke cigars,

    Q38

    4

    5629

    2.5283

    Percentage of students who smoked cigarettes on 20 or more

    QNFRCIG

    1

    5271

    2.3675

    Percentage of students who used any tobacco during the past

    QNANYTOB

    .

    5215

    2.3423

    Percent age of students who usually got their own cigarettes

    QN32

    1

    5007

    2.2489

    During the past 30 days, on how many days did you smoke cigarettes?

    Q32

    4

    4998

    2.2449

    During the past 30 days, on how many days did you smoke cigarettes?

    Q32

    6

    4968

    2.2314

    the days they smoked during the 30 days before the survey, among

    QN33

    1

    4957

    2.2264

    During the past 30 days, on the days you smoked, how many cigarettes

    Q33

    3

    4709

    2.1151

    During the past 30 days, on the days you smoked, how many cigarettes

    Q33

    4

    4553

    2.045

    During the past 30 days, on how many days did you smoke cigarettes?

    Q32

    3

    4486

    2.0149

    During the past 30 days, on how many days did you smoke cigars,

    Q38

    6

    3709

    1.6659

    Percent age of students who smoked a whole cigarette for the

    QN29

    .

    3686

    1.6556

    During the past 30 days, on how many days did you smoke cigarettes?

    Q32

    7

    3595

    1.6147

    During the past 30 days, on the days you smoked, how many cigarettes

    Q33

    5

    2938

    1.3196

    Percentage of students who smoked cigarettes on 20 or more

    QNFRCIG

    .

    2912

    1.3079

    (including e-cigarettes, vapes, vape pens, e-cigars, e-hookahs, hookah

    QN34

    .

    2907

    1.3057

    Percentage of students who currently smoked cigars (cigars, cigarillos,

    QN38

    .

    2835

    1.2733

    Percent age of students who smoked cigarettes on one or

    QN30

    .

    2810

    1.2621

    During the past 30 days, on the days you smoked, how many cigarettes

    Q33

    7

    2582

    1.1597

    Have you ever smoked cigarettes regularly, that is,

    Q26

    3

    2304

    1.0348

    During the past 30 days, on how many days did you smoke cigars,

    Q38

    7

    2223

    0.9985

    During the past 30 days, on the days you smoked, how many cigarettes

    Q33

    6

    2037

    0.9149

    Have you ever smoked cigarettes regularly, that is,

    Q26

    5

    481

    0.216

    Have you ever smoked cigarettes regularly, that is,

    Q26

    4

    318

    0.1428

    Weight_3

    Weight_3

    <missing>

    208601

    93.6935

    Percentage of students who were overweight

    QNOWT

    <missing>

    181492

    81.5174

    Percentage of students who are overweight

    QNOVWGT

    <missing>

    179470

    80.6092

    Percentage of students who were trying to lose weight

    QN65

    <missing>

    171268

    76.9253

    Percentage of students who were trying to lose weight

    QN67

    <missing>

    129497

    58.1638

    Weight variable*

    WEIGHT

    <missing>

    92780

    41.6723

    How much do you weigh without your shoes on?

    Q7

    1

    65002

    29.1957

    Percentage of students who were trying to lose weight

    QN67

    2

    52925

    23.7713

    Percentage of students who were trying to lose weight

    QN67

    1

    39153

    17.5856

    Percentage of students who are overweight

    QNOVWGT

    2

    34558

    15.5218

    Percentage of students who were overweight

    QNOWT

    2

    33539

    15.0641

    Percentage of students who were trying to lose weight

    QN65

    2

    25631

    11.5122

    How much do you weigh without your shoes on?

    Q7

    2

    23944

    10.7545

    Percentage of students who were trying to lose weight

    QN65

    1

    14925

    6.7036

    How much do you weigh without your shoes on?

    Q7

    3

    13398

    6.0177

    Percentage of students who were trying to lose weight

    QN65

    .

    10818

    4.8589

    How much do you weigh without your shoes on?

    Q7

    <missing>

    9219

    4.1407

    Percentage of students who were overweight

    QNOWT

    1

    6471

    2.9065

    Percentage of students who are overweight

    QNOVWGT

    1

    5499

    2.4699

    How much do you weigh without your shoes on?

    Q7

    54.43

    4428

    1.9888

    How much do you weigh without your shoes on?

    Q7

    58.97

    4389

    1.9713

    How much do you weigh without your shoes on?

    Q7

    63.5

    3965

    1.7809

    How much do you weigh without your shoes on?

    Q7

    68.04

    3872

    1.7391

    Percentage of students who are overweight

    QNOVWGT

    .

    3115

    1.3991

    Percentage of students who were overweight

    QNOWT

    .

    1140

    0.512

    Percentage of students who were trying to lose weight

    QN67

    .

    1067

    0.4792

    Weight variable*

    WEIGHT

    5.8559

    196

    0.088

    Weight variable*

    WEIGHT

    5.5349

    140

    0.0629

    Weight variable*

    WEIGHT

    5.4651

    128

    0.0575

    Weight variable*

    WEIGHT

    5.586273339

    117

    0.0526

    Weight variable*

    WEIGHT

    0.069

    114

    0.0512

    Weight variable*

    WEIGHT

    0.0231

    113

    0.0508

    Weight variable*

    WEIGHT

    5.2648

    108

    0.0485

    Weight_2

    Weight_2

    0.1884

    67

    0.0301

    Weight_2

    Weight_2

    0.1955

    60

    0.0269

    Weight_2

    Weight_2

    0.1195

    54

    0.0243

    Weight_3

    Weight_3

    0.3813

    52

    0.0234

    Weight_3

    Weight_3

    0.3042

    51

    0.0229

    Weight_2

    Weight_2

    3.0334

    51

    0.0229

    Weight_2

    Weight_2

    1.8008

    50

    0.0225

    Weight_2

    Weight_2

    1.8685

    50

    0.0225

    Weight_2

    Weight_2

    1.8942

    48

    0.0216

    Weight_3

    Weight_3

    2.055

    48

    0.0216

    Weight_3

    Weight_3

    0.4907

    46

    0.0207

    Weight_3

    Weight_3

    2.135

    44

    0.0198

    Weight_3

    Weight_3

    0.2068

    41

    0.0184

    Weight_3

    Weight_3

    0.2747

    40

    0.018